Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3007844	s-ebvabm	— (—)	9206	11781	100.00%	Distribution not available
3007844	s-ebvabm	u/ml (—)	139	149	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2004

4544

2.73

321.81

1.4

1.2

—

2004

4544

2.73

321.81

1.4

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1863

4863

2.77

320.31

1.4

1.2

—

Used for control exclusion in common control thyroid runs

2479

5097

2.51

319.76

1.3

—

Malaise and fatigue

1104

2458

3.71

318.15

1.2

—

Other disorders of kidney and ureter

515

812

6.90

315.76

1.8

1.2

—

5-aminosalicylic acid

757

1711

4.68

309.41

1.2

1.3

—

Other viral diseases

1090

3197

3.58

307.92

1.5

1.3

—

Nephropathy related operations

1527

765

28.10

307.65

1.9

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

3421

4423

4.49

307.65

1.5

1.1

—

Implicit viral Sepsis

662

1237

5.67

307.65

1.6

1.2

—

Other/unspecified cytomegaloviral diseases

270

145

29.63

307.65

1.7

1.4

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2705

5565

3.26

307.65

1.6

1.1

—

Inflammatory bowel disease

1095

2945

3.91

307.65

1.2

1.3

—

Implicit bacterial Sepsis

1071

1950

5.07

307.65

1.4

1.2

—

Implicit bacterial Sepsis

1127

2150

4.70

307.65

1.4

1.2

—

L04AD Calcineurin inhibitors

1693

847

31.21

307.65

1.9

1.1

—

Bacterial infection, other or unspecified

1812

3045

5.27

307.65

1.4

1.2

—

Septicaemia

1208

2314

5.10

307.65

1.6

1.2

—

Aplastic and other anaemias

1104

2622

4.07

307.65

1.5

1.2

—

Dialysis, with operation codes

1519

748

27.89

307.65

1.8

1.2

—

Oral corticosteroids

2502

5356

2.84

307.65

1.2

—

Inflammatory bowel disease, strict (require KELA)

936

2230

4.48

307.65

1.2

1.3

—

L04AA Selective immunosuppressants

1678

1735

11.32

307.65

1.8

1.2

—

Noninfective enteritis and colitis

1389

4273

3.38

307.65

1.3

—

Donors of organs and tissues

248

44.55

307.65

1.9

1.1

—

IBD patients in KELA-register

936

2192

4.56

307.65

1.2

1.3

—

Azathioprine

775

1168

7.32

307.65

1.8

1.3

—

Glomerular diseases

961

1277

8.40

307.65

1.8

1.2

—

Diseases of liver

1309

2425

5.77

307.65

1.2

—

Fever of other and unknown origin

2375

3419

6.57

307.65

1.4

1.2

—

Disorders resulting from impaired renal tubular function

394

241

22.65

307.65

1.9

1.2

—

Renal tubulo-interstitial diseases

2426

5319

3.51

307.65

1.6

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2780

5485

3.61

307.65

1.4

1.2

—

Other diseases of blood and blood-forming organs, wide

762

1564

5.19

307.65

1.4

1.3

—

Renal failure

1876

2157

8.27

307.65

1.7

1.1

—

Implicit viral Sepsis

826

1823

4.74

307.65

1.5

1.2

—

Implicit Sepsis

1805

4653

2.90

307.65

1.4

1.2

—

Chronic kidney disease

1573

1430

11.94

307.65

1.8

1.2

—

ILD medications

3702

4660

4.48

307.65

1.5

1.1

—

Inflammatory bowel disease treatment related agents

3086

5733

3.10

307.65

1.4

1.2

—

Care involving dialysis

1147

438

39.73

307.65

1.9

1.2

—

Bacterial infection, other or unspecified

1706

2780

5.59

307.65

1.4

1.2

—

ILD medications: azathioprine

775

965

8.88

307.65

1.8

1.1

—

Infections, IBD-co-morbidities

636

715

6.75

307.65

1.5

1.3

—

Autoimmune diseases excluding thyroid diseases

2670

5334

2.80

307.65

1.3

—

Autoimmune diseases

2589

5390

2.49

307.65

1.3

—

Transplanted organ and tissue status

1820

649

49.41

307.65

1.9

1.1

—

Acute renal failure

720

1035

7.42

307.65

1.5

1.1

—

Implicit Sepsis

1730

4138

3.24

307.65

1.4

1.2

—

Cytomegalovirus infection, IBD co-morbidity

292

172

25.57

307.65

1.7

1.4

—

Bacterial Sepsis

1212

2342

4.60

307.65

1.4

1.2

—

ILD medications: immunosuppressive drugs

3108

3978

7.82

307.65

1.6

1.1

—

Persons encountering health services for specific procedures and health care

2949

5863

3.10

307.65

1.5

1.2

—

Caries of dentine

993

1507

6.91

307.65

1.6

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

2616

5221

2.81

307.65

1.3

—

Other dialysis

470

236

33.51

307.65

1.9

1.4

—

Preparatory care for dialysis

564

262

32.55

307.65

1.6

1.2

—

Dental caries

1137

1704

6.91

307.65

1.6

1.2

—

Extracorporeal dialysis

822

404

30.80

307.65

1.9

1.2

—

All chronic kidney diseases

1904

2997

5.48

307.65

1.7

1.2

—

Secondary hypertension

623

433

16.90

307.65

1.9

1.2

—

Other bacterial diseases

2568

5031

3.54

307.65

1.4

1.2

—

Explicit Sepsis

1263

2675

4.60

307.65

1.6

1.2

—

Certain infectious and parasitic diseases

2205

3860

2.92

307.65

1.3

1.2

—

Enlarged lymph nodes

617

945

7.00

307.65

1.3

1.2

—

Failure and rejection of transplanted organs and tissues

241

115

39.74

307.65

2.0

1.4

—

Other septicaemia

1099

2023

5.47

307.65

1.6

1.2

—

L04AX Other immunosuppressants

1565

4904

3.31

307.65

1.5

1.2

—

Viral Sepsis

666

1241

5.69

307.65

1.6

1.2

—

Autoimmune diseases related-to ILD

2109

6553

2.83

307.65

1.2

1.3

—

Liquid cancers, helper endpoint

1372

1959

6.50

307.65

1.3

—

General symptoms and signs

2750

4292

3.29

307.65

1.3

1.2

—

Cytomegaloviral disease

293

175

24.68

307.65

1.7

1.3

—

Other bacterial diseases

2659

5410

3.21

307.65

1.4

1.2

—

GASTRO-related operations

2241

2660

4.35

307.65

1.4

1.1

—

Any gastric operation

2241

2660

4.35

307.65

1.4

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

1131

1363

9.13

307.65

1.4

1.3

—

Heart failure, not strict

2032

3231

4.44

307.65

1.5

1.2

—

Glomerular disorders in diseases classified elsewhere

720

751

11.06

307.65

1.7

1.2

—

Dialysis

606

278

35.35

307.65

2.1

1.3

—

Kidney transplant status

1087

415

54.69

307.65

2.1

1.3

—

All kidney diseases

2602

5928

3.09

307.65

1.6

1.2

—

Anaemias

1003

1072

6.50

307.65

1.6

1.2

—

Second line medication for Crohn's disease

1729

5048

3.57

307.65

1.5

1.2

—

First line medication for Crohn's disease

3456

4648

4.16

307.65

1.5

1.1

—

Non-Hodgkin lymphoma, all, including Hilmo

497

628

8.57

307.65

1.3

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1956

5292

2.60

297.74

1.4

1.2

—

Influenza and pneumonia

2404

6645

2.35

288.13

1.4

1.2

—

Other viral diseases

1248

4163

3.10

281.31

1.5

1.3

—

Budesonide

527

975

5.78

273.22

1.2

—

Other and unspecified anaemias

908

2413

3.70

272.18

1.4

1.2

—

Other diseases of liver

595

1234

5.12

270.55

1.2

—

Other anaemias

911

2434

3.67

269.67

1.4

1.2

—

Hypertensive diseases (excluding secondary)

1295

2413

3.21

268.93

1.6

1.2

—

Any reimbursement code in KELA

1477

2492

3.04

268.68

1.4

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

2205

6471

2.33

264.66

1.4

1.2

—

Cystic kidney disease

271

249

13.69

263.54

1.8

1.3

—

Unspecified kidney failure

336

409

8.81

258.45

1.7

1.1

—

All pneumoniae

2225

6617

2.29

256.03

1.4

1.3

—

Myeloid leukaemia

222

154

18.21

255.45

1.4

1.3

—

Polycystic kidney disease

241

196

15.92

254.10

1.7

1.3

—

Cystic kidney disease

271

265

12.60

251.93

1.8

1.3

—

Ulcerative colitis

799

2206

3.80

248.36

1.2

1.3

—

Pneumonia, organism unspecified

1940

5818

2.38

247.13

1.4

1.2

—

Covid-19 confirmed case

919

2794

3.41

244.85

1.4

1.2

—

Glomerulonephritis

428

732

6.40

242.62

2.0

1.3

—

Diabetic nephropathy

509

1005

5.35

240.97

1.6

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

334

442

8.26

240.65

1.3

—

Heart failure and antihypertensive medication

641

892

4.89

240.63

1.5

1.2

—

Gastrointestinal diseases

1369

2366

2.96

238.86

1.3

1.2

—

Diabetic nephropathy, excluding more controls

507

792

5.65

238.34

1.6

1.2

—

Non-follicular lymphoma

355

515

7.49

235.51

1.3

1.2

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

476

922

5.51

234.50

1.3

—

Other inflammatory liver diseases

309

391

8.80

232.09

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2094

6557

2.22

224.72

1.4

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

162

26.62

223.70

1.4

1.3

—

Provisional assignment of new diseases of uncertain etiology

1261

4810

2.69

222.23

1.4

1.2

—

Codes for special purposes

1262

4818

2.69

222.02

1.4

1.2

—

Agranulocytosis

414

746

5.99

221.50

1.4

1.2

—

Hypertension

1634

3744

2.51

219.48

1.6

1.2

—

Hypertensive diseases

1635

3751

2.51

219.15

1.6

1.2

—

Intestinal infectious diseases

2036

7160

2.20

218.87

1.5

1.2

—

Fibrosis and cirrhosis of liver

301

402

8.20

215.28

1.4

1.2

—

Congenital malformations of the urinary system

351

576

6.98

209.92

1.8

1.4

—

Crohn disease

519

1192

4.67

209.25

1.2

1.3

—

Acute peritonitis

286

374

8.47

208.80

1.7

1.2

—

Certain infectious and parasitic diseases

1416

2694

2.68

207.98

1.3

1.2

—

Secondary uncertain malignant neoplasm

370

635

6.16

207.07

1.3

—

Ulcerative colitis (strict definition, require KELA)

610

1592

4.07

206.66

1.2

1.3

—

Abnormal findings on examination of blood, without diagnosis

1007

3244

2.93

205.07

1.3

—

Anaemia in chronic diseases classified elsewhere

181

129

17.36

204.67

1.8

1.3

—

COPD/asthma/ILD related infections

2004

4547

2.24

203.82

1.3

1.2

—

COPD/asthma related infections

2004

4547

2.24

203.82

1.3

1.2

—

Congenital malformations of the urinary system

354

604

6.66

203.20

1.8

1.4

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

631

1706

3.91

203.03

1.2

1.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

597

1555

4.08

202.91

1.2

1.3

—

Heart failure,strict

887

1970

3.25

201.84

1.4

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

1620

3941

2.42

201.29

1.6

1.2

—

Examination and observation for other reasons

1254

2715

2.73

199.09

1.3

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

1655

5427

2.31

198.18

1.4

1.2

—

Hernia of abdominal wall, postoperative

341

563

6.25

197.24

1.5

1.1

—

Other disorders involving the immune mechanism, not elsewhere classified

238

276

10.52

195.17

1.7

1.4

—

Other heart diseases

1123

2693

2.79

192.04

1.5

1.2

—

Certain disorders involving the immune mechanism

569

1494

4.01

190.53

1.5

1.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

227

260

10.72

188.16

1.7

1.4

—

Hepatic failure, not elsewhere classified

200

190

12.06

187.45

1.3

1.2

—

Headache

1241

3978

2.54

187.17

1.3

1.2

—

6-mercaptopurine

226

269

9.77

179.98

1.2

1.3

—

Bronchitis

2116

6646

2.04

179.87

1.3

1.2

—

Purpura and other haemorrhagic conditions

444

1015

4.65

179.57

1.3

—

Cardiovascular diseases

1588

3740

2.33

179.17

1.5

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

571

1568

3.82

179.08

1.3

—

Metabolic disorders

1788

5102

2.17

178.30

1.4

1.2

—

Lung transplantation

131

35.41

178.15

1.2

1.5

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

393

820

5.03

177.01

1.3

—

Gout, FINNGEN

558

1512

3.79

176.21

1.4

1.2

—

Lung transplant status

130

35.12

176.19

1.2

1.5

—

Hyperparathyroidism

425

935

4.68

175.88

1.7

1.2

—

Medical observation and evaluation for suspected diseases and conditions

1326

2734

2.52

175.04

1.3

1.2

—

Acute myeloid leukaemia, including Hilmo

115

37.79

174.80

1.4

—

Acute myeloid leukaemia, helper endpoint

115

37.79

174.80

1.4

—

Acute myeloid leukaemia

115

37.79

174.80

1.4

—

Mucosal proctocolitis

470

1157

4.33

172.83

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

2004

6594

2.03

171.84

1.4

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

1510

6270

2.21

170.72

1.5

1.2

—

Cholangitis (primary sclerosing, PSC)

259

380

7.46

170.48

1.4

1.3

—

Disorders of parathyroid gland

458

1094

4.29

170.16

1.6

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

197

209

10.51

169.98

1.3

1.2

—

Diffuse large B-cell lymphoma, including Hilmo

197

209

10.51

169.98

1.3

1.2

—

Diffuse large B-cell lymphoma

197

209

10.51

169.98

1.3

1.2

—

Chronic nephritic syndrome

212

251

9.66

169.06

1.8

1.2

—

Hypertension, essential

1433

3515

2.35

167.57

1.4

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

1286

2733

2.50

167.49

1.4

1.2

—

Ulcerative colitis, NAS

476

1213

4.16

166.69

1.3

—

Gout

558

1356

3.73

166.23

1.4

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

770

1163

3.39

166.18

1.3

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2154

5975

1.99

165.52

1.4

1.2

—

Acute upper respiratory infections

1964

6057

2.03

164.31

1.3

1.2

—

IgA nephropathy (IgA glomerulonephritis)

184

191

11.86

164.13

1.7

1.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1305

2734

2.46

162.84

1.3

1.2

—

Nausea and vomiting

640

1955

3.31

162.76

1.6

1.3

—

Thrombocytopenia, unspecified

275

452

6.62

162.17

1.3

—

Cirrhosis of liver, NAS

224

297

8.36

161.74

1.4

1.2

—

Symptoms and signs involving the digestive system and abdomen

1970

4901

2.04

159.66

1.4

1.3

—

Other pulmonary diagnosis

1492

3315

2.29

159.53

1.3

1.2

—

2095

5518

1.99

159.22

1.3

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

308

579

5.80

158.11

1.2

—

Excluding asthma or asthma-COPD overlap

1486

3315

2.28

157.44

1.3

1.2

—

Persons encountering health services in other circumstances, wide

2218

5980

1.94

156.06

1.4

1.2

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

484

1311

3.90

155.45

1.2

1.3

—

Non-Hodgkin lymphoma, all

168

162

11.39

154.74

1.3

1.1

—

COPD differential diagnosis

1476

3314

2.26

154.10

1.3

1.2

—

ILD differential diagnosis

1476

3314

2.26

154.08

1.3

1.2

—

Diseases of peritoneum

316

621

5.41

153.25

1.6

1.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1132

4347

2.37

151.54

1.3

1.2

—

Acute tubulo-interstitial nephritis

1113

4093

2.39

150.16

1.5

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

321

657

5.26

149.16

1.2

—

Oedema, not elsewhere classified

536

1579

3.43

145.86

1.4

1.2

—

Intestinal infectious diseases

2145

6552

1.90

145.74

1.4

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP)

308

626

5.36

144.87

1.2

—

Lymphoid leukaemia

228

362

6.92

139.53

1.2

1.4

—

Percutaneous Coronary Intervention

1333

3756

2.21

139.04

1.5

1.3

—

Multiple myeloma, including Hilmo

164

178

10.07

138.66

1.7

1.2

—

Other Crohn's disease

294

596

5.36

138.61

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

296

606

5.36

138.43

1.2

1.3

—

Crohn disease (strict definition, require KELA)

298

615

5.31

138.05

1.2

1.3

—

Other disorders of fluid, electrolyte and acid-base balance

569

1733

3.21

137.52

1.6

1.2

—

Coronary revascularization (ANGIO or CABG)

1329

3757

2.20

137.09

1.5

1.3

—

Heart failure, strict

909

2541

2.57

136.73

1.4

1.2

—

ILD, hospital admission 2, with pulmonary infections

234

387

6.34

135.89

1.2

—

Nephrotic syndrome

192

264

8.48

135.89

2.6

1.5

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

321

712

4.84

135.49

1.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

304

648

5.12

135.35

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

277

335

6.10

135.11

1.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

461

847

3.87

134.44

1.5

1.2

—

Tramadol

1405

4116

2.13

133.78

1.3

1.2

—

Emergency coronary revascularization (for ACS)

1375

3977

2.13

131.31

1.4

1.3

—

Oesophageal varices

185

252

8.18

130.76

1.4

1.3

—

Systemic connective tissue disorders

679

2487

2.80

130.28

1.2

—

Antihypertensive medication - note that there are other indications

1478

3802

2.10

129.95

1.6

1.2

—

Ascites

221

363

6.47

129.75

1.3

1.2

—

Abdominal and pelvic pain

1857

4898

1.93

128.90

1.3

—

Hard cardiovascular diseases

1408

4071

2.09

127.53

1.4

1.3

—

Polyarthropathies

1353

4261

2.11

127.47

1.3

—

Genitourinary diseases

1301

3020

2.20

126.41

1.6

1.2

—

Care involving use of rehabilitation procedures

1055

4388

2.25

125.41

1.4

1.2

—

Complications of medical and surgical care

1286

5787

2.08

124.87

1.4

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

113

15.42

124.70

1.7

1.1

—

Multiple myeloma

113

15.42

124.70

1.7

1.1

—

Ischemic heart diseases

1370

3985

2.10

124.69

1.4

1.3

—

Chronic lymphocytic leukaemia

122

101

13.53

124.58

1.1

—

Chronic lymphocytic leukaemia, helper endpoint

122

101

13.53

124.58

1.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

122

101

13.53

124.58

1.1

—

Other heart diseases, wide

1783

5818

1.90

124.22

1.4

1.3

—

Major coronary heart disease event

1357

3969

2.09

123.44

1.4

1.3

—

Heart failure and coronary heart disease

659

1652

2.88

123.41

1.4

1.2

—

All-cause Heart Failure

864

2480

2.50

123.32

1.4

1.2

—

Abnormal serum enzyme levels

578

1945

2.98

123.25

1.2

—

Endocrine, nutritional and metabolic diseases

1696

4447

1.96

123.13

1.4

1.2

—

Other medical care

736

2564

2.63

123.04

1.2

1.1

—

Crohn disease (strict definition, all UC cases excluded)

229

421

5.98

120.80

1.2

1.3

—

Opioids

1850

5184

1.88

119.60

1.3

1.2

—

Chronic hepatitis, not elsewhere classified

159

203

8.76

118.86

1.3

1.2

—

Alcoholic liver disease

266

561

5.00

118.66

1.2

—

Oxycodone

643

2153

2.76

117.88

1.3

1.2

—

All influenza

554

1923

2.96

117.76

1.6

1.3

—

Disorders of other endocrine glands

923

4024

2.31

117.44

1.6

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

833

2122

2.52

117.41

1.3

1.2

—

Erysipelas

808

2967

2.45

116.21

1.3

1.2

—

Asthma, excluding more controls

1255

3107

2.13

115.61

1.2

—

Complications of surgical and medical care, not elsewhere classified

1715

6412

1.86

114.02

1.4

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

529

1773

3.03

113.66

1.8

1.4

—

Hypertensive Renal Disease

128

130

10.64

113.40

1.5

1.1

—

Autoimmune hepatitis

29.53

111.99

1.3

1.6

—

Myelodysplastic syndrome, including Hilmo

112

12.83

111.57

1.3

1.1

—

Other noninfective gastroenteritis and colitis

571

2080

2.83

111.01

1.4

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1084

4759

2.12

110.70

1.4

1.3

—

Haemolytic anaemias

160

224

7.97

110.48

1.3

1.4

—

Reimbursement for rheumatic diseases

1026

4855

2.14

109.65

1.2

1.3

—

Multiple myeloma and malignant plasma cell neoplasms

161

228

7.66

109.35

1.7

1.2

—

Viral infections characterized by skin and mucous membrane lesions

872

3896

2.29

109.05

1.5

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

536

1854

2.93

108.93

1.8

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

196

339

6.06

108.84

1.2

—

Diseases of oesophagus, stomach and duodenum

1849

6220

1.80

108.29

1.3

—

Other disorders of skin and subcutaneous tissue

1139

4992

2.06

107.67

1.4

1.2

—

Other viral diseases, not elsewhere classified

521

1841

2.93

107.36

1.7

1.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1027

4856

2.12

107.15

1.4

1.2

—

Other viral diseases, not elsewhere classified

687

2782

2.53

106.83

1.6

1.3

—

Acquired haemolytic anaemia

124

133

10.64

106.67

1.4

1.2

—

Leukaemia of unspecified cell type

20.43

106.48

1.3

1.2

—

Erysipelas

1026

3689

2.15

106.06

1.3

1.2

—

Other respiratory diseases principally affecting the interstitium

340

935

3.75

105.98

1.2

—

Asthma

1270

3287

2.05

105.95

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

1927

5472

1.79

105.53

1.3

—

Abnormalities of breathing

1694

5425

1.84

105.40

1.3

—

Diseases of the skin and subcutaneous tissue

1811

5066

1.81

104.53

1.3

1.2

—

Fungal Sepsis

149

204

7.96

104.38

1.5

1.2

—

Other diseases of intestines

1990

6556

1.75

104.35

1.3

—

Crohn's disease of small intestine

253

574

4.72

103.92

1.2

1.3

—

Other bacterial intestinal infections

384

1162

3.41

103.41

1.4

1.2

—

Malignant neoplasm, wide definition for exclusion

1483

4625

1.90

103.33

1.3

—

Malignant neoplasm

1423

4421

1.93

103.20

1.3

—

Implicit fungal Sepsis

190

337

5.98

103.15

1.5

1.2

—

Insulin, fast-acting

747

3211

2.38

102.48

1.5

1.3

—

Pain, not elsewhere classified

491

1719

2.92

102.47

1.2

—

Insulin medication

1084

4505

2.06

101.16

1.4

1.3

—

Disorders of gallbladder, biliary tract and pancreas

1595

5546

1.83

100.89

1.3

1.2

—

Anxiety disorders, excluding more controls

1541

5495

1.85

100.32

1.3

—

Abnormal findings on diagnostic imaging of lung

711

2883

2.40

99.92

1.3

1.2

—

Factors influencing health status and contact with health services

523

862

3.09

99.14

1.3

1.1

—

Bleeding

1343

5063

1.91

98.78

1.4

1.3

—

Neurotic, stress-related and somatoform disorders

1682

6686

1.78

98.78

1.3

—

Anxiety disorders

1691

6716

1.78

98.16

1.3

—

Viral pneumonia

314

865

3.78

98.01

1.5

1.2

—

Persons encountering health services for examination and investigation

1126

2734

2.09

97.65

1.3

1.2

—

Hyperkalaemia

156

241

6.86

97.24

1.6

1.1

—

Implicit fungal Sepsis

138

189

7.96

96.70

1.5

1.2

—

Insulin, fast-acting or short human

749

3319

2.31

95.70

1.5

1.3

—

Biological medication for rheuma

485

1765

2.86

95.31

1.2

1.3

—

Parasetamol

1517

4187

1.86

94.82

1.3

1.2

—

Disorders of lens

1040

3158

2.08

94.67

1.4

1.2

—

Viral infections characterized by skin and mucous membrane lesions

1555

7560

1.78

94.43

1.4

1.3

—

Asthma (only as main-diagnosis), excluding more controls

1101

3107

2.05

94.16

1.2

—

Colitis, primary sclerosing

110

121

11.19

94.16

1.4

1.3

—

Asthma (mode)

1214

3314

1.98

93.40

1.2

—

Gout, idiopatic and unspecified

411

1377

3.06

93.10

1.4

1.2

—

Bacterial intestinal infections, IBD co-morbidities

378

1209

3.22

93.00

1.4

1.2

—

Noninfectious colitis NAS

349

1068

3.40

92.76

1.3

—

Other disorders of white blood cells

182

344

5.69

92.70

1.3

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

124

161

9.14

92.58

1.5

—

ILD, hospital admissions 1, main diag only

270

697

4.02

92.43

1.2

—

Other bacterial intestinal infections

451

1603

2.89

91.90

1.3

1.2

—

Cerebrovascular diseases (FINNGEN)

512

1315

2.81

91.64

1.4

1.2

—

Dependence on enabling machines and devices, not elsewhere classified

100

12.63

91.58

3.6

1.1

—

Other interstitial pulmonary diseases

286

775

3.81

91.24

1.2

—

Interstitial lung disease

286

777

3.80

90.90

1.2

—

Interstitial lung disease endpoints

286

777

3.80

90.90

1.2

—

ILD, hospital admissions

284

771

3.81

90.38

1.2

—

Pneumocystosis

105

114

10.77

89.94

1.3

—

Cardiomyopathy

341

1047

3.35

89.69

1.5

1.2

—

Hypothyroidism (congenital or acquired)

567

1203

2.72

89.26

1.3

1.2

—

Gout, unspecified

346

1077

3.30

88.92

1.4

1.2

—

Atrial fibrillation and flutter

493

1141

2.85

88.75

1.3

1.2

—

Unspecified jaundice

150

245

6.51

88.69

1.4

1.3

—

Rare circulating lymphoid malignancy, including Hilmo

141

220

7.17

88.26

1.4

1.5

—

Insulin, intermediate and long-acting

922

4432

2.05

88.14

1.4

1.3

—

Crohn's disease NAS

226

538

4.48

87.29

1.3

—

Neoplasms

1572

4733

1.78

86.89

1.4

1.3

—

Diabetic maculopathy, excluding more controls

274

748

3.82

86.86

1.7

1.2

—

Asthma, unspecified (mode), excluding more controls

791

2724

2.20

86.46

1.3

1.2

—

Other necrotizing vasculopathies

182

366

5.24

86.01

1.3

1.2

—

343

1088

3.27

85.93

1.5

1.2

—

Infections of the skin and subcutaneous tissue

1130

5996

1.90

85.88

1.4

1.3

—

Asthma (only as main-diagnosis)

1108

3287

1.97

85.73

1.2

—

Enterocolitis due to Clostridium difficile

238

594

4.17

85.46

1.4

1.2

—

Toxic liver disease

12.61

85.40

1.2

—

Other ulcerative colitis

201

446

4.82

84.93

1.3

—

Other acute lower respiratory infections

993

4871

1.97

84.58

1.4

1.3

—

Other diseases of biliary tract

204

457

4.67

84.49

1.5

1.2

—

Type 2 diabetes, wide definition

1167

3954

1.91

84.25

1.4

1.2

—

Ulcer of lower limb, not elsewhere classified

271

754

3.71

83.19

1.5

1.2

—

Hypothyroidism and >3 levothyroxin purchases

547

1184

2.66

83.11

1.3

1.2

—

Hypothyroidism, levothyroxine purchases

547

1184

2.66

83.11

1.3

1.2

—

Dermatitis and eczema

1907

7238

1.65

83.05

1.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

149

260

6.01

82.12

1.2

—

Infectious mononucleosis

323

1025

3.34

81.74

1.2

—

Pneumonia due to other infectious organisms, not elsewhere classified

121

175

7.51

80.76

1.3

1.2

—

Any event in cancer register

1514

5163

1.75

80.24

1.3

—

Nonalcoholic fatty liver disease

269

769

3.67

79.94

1.2

—

Diseases of the respiratory system

1072

2758

1.97

79.56

1.2

—

Pain (limb, back, neck, head abdominally)

1293

3545

1.85

79.43

1.3

—

Gout, strict definition

306

949

3.32

79.23

1.5

1.2

—

Dyspnoea

1432

6138

1.74

79.06

1.3

—

Symptoms and signs involving the skin and subcutaneous tissue

1162

6318

1.82

78.21

1.3

—

Other reaction to severe stress, and adjustment disorders

774

3775

2.09

77.76

1.4

1.2

—

Streptococcal septicaemia

193

442

4.55

77.69

1.5

1.3

—

Asthma, unspecified (mode)

794

2881

2.10

77.43

1.3

1.2

—

Nutritional anaemias

752

3492

2.11

77.15

1.4

1.2

—

Osteopathies and chondropathies

910

4366

1.97

77.05

1.3

—

Non-ischemic cardiomyopathy

453

1386

2.68

77.01

1.4

1.2

—

Tumor necrosis factor alpha inhibitors

420

1586

2.75

76.92

1.2

1.3

—

Gingival hyperplasia

160

322

5.50

76.76

3.0

1.3

—

Maternal care for other conditions predominantly related to pregnancy

495

1983

2.52

76.36

1.2

—

Cardiomyopathies, Primary/intrinsic

246

681

3.73

76.19

1.5

1.3

—

Drug-induced neutropenia

191

443

4.55

76.07

1.3

1.2

—

Iron deficiency anaemia

671

3074

2.19

75.89

1.4

1.2

—

Depression medications

642

1378

2.38

75.44

1.3

1.2

—

Diabetic retinopathy, strict definition

371

1153

2.95

75.40

1.6

1.2

—

Cardiomyopathy (excluding other)

251

711

3.65

75.10

1.5

1.3

—

IBD (strict) with PSC

13.07

75.09

1.4

1.3

—

Hypoplasia of dental enamel

118

193

9.12

74.71

4.1

1.7

—

Crohn's disease of large intestine

182

414

4.71

74.67

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

1178

6353

1.79

74.31

1.4

1.3

—

Dermatitis

1000

5381

1.88

74.11

1.4

1.2

—

Postviral fatigue syndrome

14.03

73.74

1.3

—

Diseases of the digestive system

743

3625

2.07

73.24

1.4

1.3

—

Codeine

1543

4990

1.70

72.78

1.2

—

Other and unspecified aplastic anaemias

15.09

72.52

1.4

—

Disorders of lipoprotein metabolism and other lipidaemias

1144

3904

1.83

72.41

1.4

1.2

—

Explicit bacterial Sepsis

227

617

3.81

72.29

1.4

1.2

—

Syncope and collapse

597

2285

2.27

72.19

1.3

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

1248

6670

1.75

71.98

1.4

1.2

—

Any death

859

3136

1.99

71.22

1.2

—

Other and unspecified dermatitis

864

4517

1.94

70.96

1.4

1.2

—

Colitis, primary sclerosing, strict definition

11.29

70.85

1.4

1.3

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

124

211

6.29

70.59

1.3

1.1

—

Type 1 diabetes

563

2526

2.28

70.03

1.5

1.3

—

Atrial fibrillation and flutter with reimbursement

350

748

3.03

69.67

1.3

1.2

—

Venous thromboembolism

751

3630

2.02

69.46

1.3

1.2

—

Acute sinusitis

922

4584

1.89

68.83

1.3

1.2

—

Drug-induced cataract

106

160

7.41

68.53

2.0

1.3

—

Protozoal diseases

117

195

6.60

68.51

1.3

1.2

—

Bacterial pneumonia (organism specified)

701

3121

2.07

67.72

1.4

1.3

—

Other infectious diseases

213

583

3.81

67.39

1.4

1.2

—

Heart failure and bmi 25plus

474

1303

2.50

67.12

1.3

1.2

—

Other autoimmune haemolytic anaemias

13.65

66.72

1.2

—

Pain in joint

986

3403

1.87

66.70

1.2

1.3

—

Other and unspecified polyneuropathies, also in other diseases

323

1146

2.89

66.23

1.4

1.2

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

234

690

3.54

66.22

1.6

1.2

—

Anxiety (asthma-related co-morbidities)

1172

5248

1.75

66.15

1.3

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

141

288

5.28

66.04

1.5

1.2

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

160

360

4.62

65.91

1.3

1.2

—

Hepatocellular carcinoma, including Hilmo

120

8.17

65.79

1.2

—

Vitreous haemorrhage

224

645

3.61

65.67

1.6

1.2

—

Other and unspecified disorders of white blood cells

131

252

5.58

65.58

1.3

—

Idiopathic pulmonary fibrosis

149

318

4.87

65.49

1.1

1.2

—

Bacterial pneumoniae

608

2521

2.16

65.43

1.4

1.2

—

All anxiety disorders

1200

5550

1.73

65.37

1.3

—

Bacterial pneumonia, not elsewhere classified

579

2356

2.20

65.16

1.4

1.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

113

189

6.28

65.15

1.3

1.2

—

Other infectious diseases

181

453

4.17

65.02

1.5

1.2

—

Complications of procedures, not elsewhere classified

1228

6002

1.71

64.95

1.4

1.2

—

Pain in throat and chest

1404

5084

1.67

64.64

1.3

—

Mood disorders, excluding more controls

1532

5651

1.63

64.03

1.3

1.2

—

Polyneuropathies and other disorders of the peripheral nervous system

364

1398

2.67

64.00

1.4

1.3

—

Hypertensive heart and/or renal disease

346

930

2.82

63.95

1.5

1.2

—

Acute bronchitis

682

3340

2.03

63.79

1.4

1.3

—

Depression

1636

7017

1.60

63.59

1.3

—

Diabetic retinopathy, excluding more controls

456

1026

2.55

63.42

1.5

1.2

—

Molar incisor enamel hypoplasia, with caries

101

165

8.71

63.39

3.9

1.5

—

Pulmonary heart disease, diseases of pulmonary circulation

456

1951

2.38

63.30

1.3

1.2

—

Cardiomyopathy, other and unspecified

175

436

4.18

63.21

1.4

1.2

—

Diseases of the eye and adnexa

1564

4836

1.64

63.20

1.3

—

Mycoses

487

2152

2.31

63.03

1.4

1.2

—

Finngen Rheumatological endpoints

1638

5866

1.60

62.80

1.2

1.3

—

Idiopathic thrombocytopenic purpura

113

198

6.22

62.76

1.3

1.4

—

Senile cataract

816

2585

1.96

62.70

1.4

1.2

—

Diseases of arteries, arterioles and capillaries

887

3537

1.87

62.37

1.4

1.2

—

Other and unspecified iron deficiency

529

2425

2.22

62.27

1.4

1.2

—

Other diseases of the digestive system

488

2168

2.29

62.10

1.5

1.3

—

Other necrotizing vasculopathies (FG)

137

288

4.98

61.48

1.3

1.2

—

Adjustment and management of implanted device

243

764

3.24

61.42

1.4

1.2

—

Myelodysplastic syndrome

20.81

61.34

1.4

1.1

—

Other diseases of pericardium

124

241

5.45

61.14

1.5

1.2

—

Disorders of mineral metabolism

188

507

3.86

60.80

1.5

1.2

—

Pericarditis

109

190

6.11

60.52

1.3

1.2

—

Infliximab

104

177

6.70

60.24

1.1

1.2

—

Other cataract

612

2233

2.10

59.93

1.4

1.2

—

Other diseases of pleura

603

2566

2.09

59.71

1.3

1.2

—

Viral hepatitis, IBD co-morbidity

153

360

4.44

59.70

1.2

—

GI-bleeding

481

2160

2.26

59.64

1.5

1.3

—

Malignant neoplasm of liver and intrahepatic bile ducts

108

8.12

59.26

1.3

1.2

—

Gout due to impairment of renal function

13.26

59.23

1.6

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

845

4642

1.84

59.19

1.4

1.2

—

Acute pharyngitis

396

1635

2.48

59.05

1.4

1.3

—

Other soft tissue disorders, not elsewhere classified

1599

5975

1.58

58.62

1.3

—

Other systemic involvement of connective tissue (FG)

407

1695

2.41

58.31

1.2

—

Zoster [herpes zoster]

308

1141

2.76

58.23

1.3

1.2

—

Primary biliary cholangitis (PBC)

10.46

57.88

1.3

—

Osteoporosis

347

1269

2.60

57.74

1.3

1.2

—

Neurological diseases, wide definition

669

1637

2.08

57.67

1.3

—

Mood [affective] disorders

1684

7130

1.54

56.52

1.2

1.3

—

Asthma-related infections

989

5651

1.73

56.43

1.3

—

Asthma, hospital admission 2, infections

989

5651

1.73

56.43

1.3

—

Chronic tubulo-interstitial nephritis

104

185

5.95

56.43

1.5

1.1

—

Mood disorders

1686

7132

1.54

56.39

1.2

1.3

—

Need for immunization against other single viral diseases

141

7.15

56.27

1.6

1.3

—

Sub-endpoint used in defining T1D endpoints

564

2721

2.08

55.82

1.5

1.3

—

Cardiac arrhythmias

1008

3777

1.75

55.72

1.3

1.2

—

Type 1 diabetes, wide definition, subgroup 1

463

2116

2.24

55.31

1.6

1.3

—

Gingivitis and periodontal diseases

1564

5165

1.58

54.77

1.3

1.2

—

Presence of cardiac and vascular implants and grafts

491

1668

2.21

54.74

1.3

1.1

—

Zoster [herpes zoster]

682

3535

1.92

54.73

1.3

1.2

—

Amputation

177

491

3.71

54.72

1.5

1.1

—

Other retinal disorders

857

3731

1.81

54.59

1.4

1.2

—

Hypo-osmolality and hyponatraemia

251

858

2.97

54.43

1.6

1.2

—

Hepatocellular carcinoma

9.10

54.39

1.2

1.1

—

Cutaneous abscess, furuncle and carbuncle

510

2441

2.13

54.20

1.4

1.2

—

Coronary atherosclerosis

792

2706

1.87

53.92

1.4

1.2

—

Type 1 diabetes, wide definition

477

2231

2.18

53.72

1.6

1.3

—

DVT of lower extremities and pulmonary embolism

555

2731

2.05

53.67

1.3

1.2

—

Diseases of the musculoskeletal system and connective tissue

1103

3257

1.72

53.43

1.3

—

Peripheral artery operations in Hilmo

195

585

3.41

53.31

1.5

1.2

—

Insulin, fast-acting (human)

324

1299

2.57

52.48

1.6

1.2

—

SLE (Finngen)

163

6.11

52.44

1.2

1.3

—

Disorders of calcium metabolism

143

353

4.23

52.43

1.5

1.2

—

Other systemic involvement of connective tissue

420

1888

2.26

52.14

1.2

—

Dilated cardiomyopathy

220

725

3.13

51.80

1.4

1.3

—

Abnormal results of function studies

213

692

3.20

51.62

1.3

—

Diabetic maculopathy

262

894

2.86

51.48

1.7

1.2

—

Ulcerative rectosigmoiditis

200

627

3.32

51.43

1.2

—

Pure hypercholesterolaemia

925

3479

1.75

51.21

1.3

1.2

—

Valvular heart disease excluding rheumatic fever

637

2377

1.96

51.06

1.4

1.3

—

806

4538

1.79

51.03

1.3

—

Codeine or tramadol medication

1756

6452

1.50

50.10

1.2

—

Other skin changes

301

1191

2.59

49.94

1.4

1.2

—

Other diseases of hard tissues of teeth

798

2258

1.85

49.76

1.4

1.2

—

Non-rheumatic valve diseases

622

2322

1.96

49.69

1.4

1.3

—

Periodontitis

1378

5937

1.57

49.59

1.3

1.2

—

All influenza (not pneumonia)

301

1198

2.58

49.43

1.6

1.3

—

Chronic periodontitis, including avohilmo

1374

5935

1.56

49.38

1.3

1.2

—

Other gastritis (incl. Duodenitis)

332

1383

2.44

49.20

1.3

1.2

—

Gastro-oesophageal reflux disease

964

4976

1.69

49.13

1.3

—

Pulmonary embolism

398

1793

2.25

49.07

1.3

1.2

—

Statin medication

1105

3773

1.66

49.03

1.5

1.2

—

Ulcerative colitis (strict) with PSC

11.23

48.70

1.3

1.4

—

Pulmonary heart disease

398

1800

2.25

48.61

1.3

1.2

—

Cough

642

3275

1.88

47.73

1.4

1.3

—

Disorders of choroid and retina

1074

4693

1.64

47.57

1.4

1.2

—

Arthropathies in other diseases classified elsewhere

100

201

5.27

47.56

1.6

1.2

—

Other diseases of urinary system

1546

5758

1.52

47.33

1.3

—

Cystitis

1283

4866

1.58

47.16

1.3

1.2

—

Adalimumab

251

939

2.78

47.15

1.2

1.3

—

Diverticular disease of intestine

890

3314

1.73

47.07

1.2

—

Paroxysmal tachycardia

359

1301

2.35

47.00

1.3

1.2

—

Diseases of oral cavity, salivary glands and jaws

792

2264

1.82

46.90

1.3

1.2

—

Other anxiety disorders

886

4559

1.71

46.80

1.3

1.2

—

Follicular lymphoma, hilmo

104

221

4.97

46.33

1.2

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

11.53

46.23

1.7

1.2

—

Diagnoses used for exclusion with ILD

378

1713

2.24

46.07

1.3

1.2

—

Congenital malformations of gallbladder, bile ducts and liver

8.98

45.69

2.2

1.9

—

Other disorders of urethra and urinary system

1010

4465

1.65

45.63

1.4

1.2

—

Amputation of toe

136

358

3.94

45.60

1.6

1.2

—

Endocarditis

182

5.39

45.56

1.3

1.2

—

Nonischemic cardiomyopathy

180

570

3.25

45.29

1.5

1.3

—

Other or ill-defined heart diseases

135

358

3.93

44.89

1.5

1.2

—

Symptoms and signs involving the urinary system

1069

5093

1.61

44.83

1.4

1.3

—

Asthma-related pneumonia

535

2778

1.95

44.83

1.3

—

Other and unspecified tonsillitis

715

3403

1.79

44.68

1.4

1.2

—

Asthma, hospital admissions 3, pneumonia

536

2789

1.94

44.63

1.3

—

Asthma-related pneumonia or sepsis

536

2789

1.94

44.63

1.3

—

Convulsions, not elsewhere classified

382

1740

2.20

44.43

1.4

1.2

—

Chronic gastritis

338

1490

2.30

43.95

1.2

—

Molar incisor enamel hypoplasia

180

568

3.35

43.94

3.2

1.5

—

Cerebral cysts

156

464

3.52

43.88

1.4

1.3

—

Ischaemic heart disease, wide definition

957

3593

1.66

43.70

1.3

1.2

—

Urticaria and erythema

643

3580

1.82

43.68

1.4

1.3

—

Other arthritis (FG)

492

2513

1.99

43.64

1.3

1.2

—

Chronic hepatitis NAS

8.77

43.50

1.3

1.2

—

Acute pancreatitis

301

1271

2.41

43.40

1.2

—

Pain in limb

1293

5671

1.54

43.18

1.3

—

Diabetic retinopathy

509

1595

2.02

43.09

1.5

1.2

—

Cholelithiasis, broad definition with cholecystitis

1136

4875

1.58

42.88

1.2

—

Ulcerative ileocolitis

118

295

4.23

42.86

1.1

1.2

—

Peripheral artery disease

485

1943

2.01

42.85

1.4

1.2

—

Neurological diseases

1519

5123

1.50

42.82

1.3

—

Symptoms and signs concerning food and fluid intake

178

578

3.15

42.81

1.7

1.2

—

Hyperlipidaemia, other/unspecified

452

2065

2.04

42.70

1.4

1.2

—

Other viral hepatitis

181

600

3.16

42.67

1.2

—

Any mental disorder

1681

5771

1.47

42.54

1.3

—

Viral pneumonia (unknown virus, not influenza)

172

554

3.24

42.45

1.3

—

Persons encountering health services in other circumstances

657

3693

1.79

42.36

1.3

1.2

—

Early onset COPD, excluding more controls

259

1033

2.55

42.10

1.2

—

Haemorrhage from respiratory passages

465

2112

2.01

42.03

1.3

—

Diabetes, varying definitions

1545

6172

1.48

41.76

1.4

1.2

—

Hypothyroidism, strict autoimmune

976

3971

1.63

41.64

1.3

1.2

—

Non-invasive ventilation

357

1459

2.22

41.56

1.5

1.2

—

Chronic periodontitis, complicated

727

4210

1.73

41.52

1.4

1.2

—

Other diseases of intestine

218

809

2.75

41.23

1.3

1.2

—

Mature T/NK-cell lymphomas, hilmo

8.54

41.22

1.5

1.2

—

Diabetes mellitus

1550

6193

1.47

41.21

1.4

1.2

—

Sarcoidosis

239

931

2.64

41.18

1.3

1.2

—

Systemic lupus erythematosus

203

4.89

41.13

1.2

1.3

—

Type 2 diabetes

1384

5406

1.51

41.01

1.3

1.2

—

Viral hepatitis

191

668

2.98

40.87

1.2

—

Hypoplasia of dental enamel , including avohilmo

168

538

3.33

40.64

3.3

1.5

—

ILD-related respiratory insufficiency

152

5.57

40.56

1.2

—

Soft tissue disorders

1714

6144

1.45

40.38

1.3

—

Other CVD (FINNGEN)

157

364

3.41

40.36

1.3

1.2

—

STROKE

694

2692

1.77

40.30

1.3

1.2

—

Benign neoplasm: Colon

633

3421

1.78

40.17

1.2

—

Caries of enamel

1423

6996

1.48

40.03

1.4

1.2

—

Collagenous colitis

173

579

3.08

39.81

1.2

—

L01XX Other antineoplastic agents

109

271

4.18

39.65

1.2

—

Diaphragmatic hernia

450

2305

1.98

39.55

1.2

—

Other specified/unspecified arthritis

435

2208

2.00

39.38

1.3

—

Osteomyelitis

141

423

3.47

39.05

1.5

1.3

—

Solid cancers, helper endpoint

1115

4248

1.56

39.03

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

741

3825

1.70

38.85

1.2

—

Immunodeficiency with predominantly antibody defects

198

4.90

38.78

1.6

1.4

—

Hodgkin lymphoma, hilmo

235

4.53

38.77

1.4

1.2

—

Pacemaker

355

1605

2.15

38.76

1.3

1.2

—

Myocarditis

105

258

4.22

38.75

1.3

1.2

—

Arthropathies

1601

5617

1.46

38.74

1.3

—

Unspecified nephritic syndrome

142

5.70

38.41

1.8

1.1

—

Immunodeficiencies

128

366

3.68

38.39

1.5

1.3

—

Persons encountering health services for specific procedures, not carried out

183

646

2.93

38.33

1.3

1.2

—

ILD medications: pirfenidone

13.19

38.27

1.1

1.0

—

Gastroduodenal ulcer

308

1383

2.25

38.11

1.4

1.2

—

SLE, strict definition

200

4.76

38.07

1.2

—

SLE, ICD10

200

4.76

38.07

1.2

—

Cholelithiasis

1069

4778

1.55

37.76

1.2

—

Acute pancreatitis (for exclusion)

301

1352

2.27

37.67

1.2

—

Other metabolic disorders

240

978

2.51

37.64

1.4

1.2

—

Hepatomegaly and splenomegaly, not elsewhere classified

9.10

37.60

1.5

1.1

—

Other diseases of the respiratory system

270

1162

2.36

37.31

1.4

1.3

—

Other respiratory disorders and diseases

270

1162

2.36

37.31

1.4

1.3

—

Volume depletion

153

498

3.15

36.84

1.6

1.2

—

Phlebitis and thrombophlebitis (not including DVT)

334

1581

2.15

36.65

1.4

1.2

—

Charcot foot

103

6.53

36.42

1.8

1.1

—

Other acute viral hepatitis

101

6.76

36.24

1.2

—

Herpesviral [herpes simplex] infections

224

902

2.55

36.14

1.4

1.2

—

Chronic apical periodontitis

1678

6790

1.42

36.12

1.3

1.2

—

Dental operations

791

2439

1.68

36.02

1.3

1.2

—

Respiratory insufficiency

106

275

3.93

35.99

1.3

1.2

—

Diseases of spleen

101

6.55

35.95

1.4

1.2

—

Mantle cell lymphoma, including Hilmo

8.58

35.94

1.4

1.2

—

Presence of other functional implants

575

2237

1.80

35.53

1.3

1.1

—

Continuous positive airway pressure

267

972

2.35

35.30

1.5

1.3

—

Visual disturbances and blindness

741

4546

1.65

35.28

1.3

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

175

4.79

35.24

1.4

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1324

5463

1.47

35.16

1.4

1.3

—

Other diseases of anus and rectum

395

2014

1.98

35.03

1.3

—

Hypothyroidism, drug reimbursement

210

564

2.67

34.79

1.3

1.2

—

Hydronephrosis

173

625

2.83

34.56

1.6

1.2

—

Other antidepressants

1568

5670

1.43

34.32

1.2

1.3

—

Episodal and paroxysmal disorders

1753

6427

1.40

34.10

1.2

1.3

—

Seborrhoeic keratosis

275

1240

2.25

34.08

1.4

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1287

5661

1.47

34.06

1.3

1.2

—

Haemorrhage, not elsewhere classified

145

5.15

34.06

1.5

1.2

—

Viral and other specified intestinal infections

583

3273

1.75

34.04

1.7

1.2

—

Mantle cell lymphoma

11.50

33.98

1.4

1.0

—

Other disorders of lacrimal gland

482

2656

1.84

33.97

1.3

1.2

—

Secondary thrombocytopenia

8.21

33.73

1.2

—

Viral warts

217

891

2.51

33.73

2.1

1.2

—

Candidiasis

244

1054

2.37

33.70

1.4

1.2

—

Sequelae of external causes of morbidity and mortality

374

1906

1.99

33.59

1.4

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

585

2225

1.76

33.10

1.2

—

Recurrent or chronic depression

689

2927

1.67

33.01

1.2

1.3

—

Unspecified haematuria

534

2512

1.78

33.01

1.4

1.2

—

Exposure to unspecified factor

1521

7828

1.41

32.97

1.3

—

Ulcerative proctitis

142

475

3.10

32.92

1.2

—

Missing teeth due to accident, extraction or parodontitis

723

4223

1.63

32.73

1.3

1.2

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

173

647

2.75

32.52

1.3

1.2

—

Psychiatric diseases

1491

5272

1.43

32.47

1.3

—

Eosinophilic disease (BM)

7.23

31.89

1.2

1.4

—

Disorders of tooth development and eruption

298

1137

2.16

31.87

1.7

1.2

—

Disorders of skin appendages

798

5110

1.58

31.79

1.3

—

Other embolism and thrombosis

201

817

2.51

31.74

1.3

1.2

—

Candidiasis

449

2479

1.84

31.57

1.3

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1378

5868

1.43

31.45

1.4

1.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

414

1743

1.90

31.28

1.4

1.2

—

Viral pneumonia (known virus, not influenza)

186

4.53

31.25

1.7

1.4

—

Depression or dysthymia

1016

3719

1.52

31.17

1.2

1.3

—

Myeloproliferative diseases

135

452

3.07

31.12

1.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

634

3065

1.67

31.10

1.3

1.2

—

Iron deficiency anaemia secondary to blood loss (chronic)

220

940

2.38

31.06

1.4

1.2

—

Other pleural conditions

144

500

2.94

31.01

1.3

1.2

—

Abnormalities of heart beat

483

2682

1.78

30.94

1.3

1.2

—

Systemic lupus erythematosus, unspecified

179

4.54

30.86

1.2

1.3

—

Sequelae with surgical and medical care as external cause

288

1380

2.12

30.74

1.4

1.2

—

Vocal cord dysfunction

194

699

2.53

30.63

1.3

1.2

—

Undetermined asthma, excluding more controls

183

723

2.57

30.58

1.3

1.2

—

Visual disturbances

684

4269

1.62

30.54

1.3

—

Abnormal findings on diagnostic imaging of other body structures

210

887

2.42

30.52

1.3

1.2

—

Disease of hard tissues of teeth, NOS

694

2208

1.66

30.37

1.2

—

Diabetic neuropathy

192

778

2.52

30.31

1.5

1.3

—

Functional dyspepsia

369

1939

1.93

30.29

1.3

1.2

—

Osteonecrosis

116

362

3.32

30.22

1.4

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

547

3200

1.72

30.21

1.9

1.2

—

Other diseases of arteries and capillaries

146

519

2.88

30.20

1.3

1.2

—

Other diseases of blood and blood-forming organs

124

403

3.17

30.15

1.2

—

Gastric ulcer

209

885

2.40

30.05

1.4

1.2

—

Pleural effusion

192

784

2.49

29.97

1.2

—

Irritable bowel syndrome

415

2273

1.85

29.94

1.2

—

Isolated proteinuria

224

4.08

29.75

1.8

1.2

—

Viral and other specified intestinal infections

467

2599

1.78

29.55

1.8

1.2

—

Disorders of lacrimal system

558

3329

1.69

29.49

1.3

1.2

—

Undetermined asthma

183

736

2.53

29.48

1.3

1.2

—

COPD-related respiratory insufficiency

155

576

2.74

29.40

1.2

—

Other problems related to primary support group, including family circumstances

286

1357

2.11

29.34

2.5

1.3

—

Other and unspecified drugs and medicaments

163

624

2.69

29.34

1.3

1.2

—

Any operation in hilmo

5.02

29.28

1.3

1.1

—

Amiodarone users

148

540

2.81

29.16

1.2

—

Cellulitis

361

1910

1.92

29.16

1.5

1.3

—

Other functional intestinal disorders

609

3462

1.65

28.96

1.3

—

Migraine

850

4548

1.53

28.83

1.3

—

Chronic pancreatitis

184

754

2.49

28.62

1.4

1.2

—

Intestinal stricture

377

2034

1.88

28.52

1.3

1.2

—

L01XE Protein kinase inhibitors

104

315

3.43

28.50

1.2

—

Use of hypnotics and sedatives

1476

6144

1.39

28.42

1.3

—

Other nutritional deficiencies

991

6399

1.47

28.35

1.2

1.3

—

Other specific joint derangements/joint disorders

1185

5378

1.43

28.14

1.2

1.3

—

Disorders of sclera, cornea, iris and ciliary body

780

5115

1.54

28.08

1.3

1.2

—

Diseases of pulp and periapical tissues and dental caries

891

3003

1.53

27.95

1.3

1.2

—

Paralytic ileus and intestinal obstruction

302

1523

2.00

27.90

1.2

1.3

—

Amputation of ankle bones

102

5.59

27.63

1.4

1.1

—

Herpesviral [herpes simplex] infections

405

2261

1.82

27.57

1.3

1.2

—

Abnormal findings on examination of urine, without diagnosis

105

328

3.34

27.49

1.7

1.2

—

Disorders of thyroid, IBD co-morbidities

270

901

2.13

27.46

1.3

1.2

—

Disorders of vitreous body and globe

572

3373

1.64

27.14

1.3

1.2

—

Obesity related asthma

481

2831

1.72

27.13

1.2

—

Disorders of vitreous body

555

3275

1.65

26.89

1.3

1.2

—

Erythema nodosum

164

4.41

26.86

1.2

—

Sleep disorders (combined)

1670

6524

1.35

26.83

1.2

1.3

—

Asthma (diagnoses ohter than nonallergic)

1277

7655

1.39

26.75

1.2

1.3

—

Idiopathic gout

132

475

2.84

26.73

1.4

1.2

—

Unspecified acute lower respiratory infection

257

1250

2.10

26.52

1.5

1.3

—

Disorders of oesophagus in diseases classified elsewhere

5.67

26.51

1.3

1.1

—

Myocardial infarction

506

2104

1.71

26.33

1.3

1.2

—

Low back pain

1117

5659

1.43

26.32

1.2

—

Hypokalaemia

166

675

2.51

26.26

1.5

1.1

—

Cystic disease of liver

10.33

26.20

1.5

1.2

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

8.91

26.10

1.5

1.2

—

Diabetes medication

1461

6368

1.37

26.08

1.4

1.2

—

Diseases of middle ear and mastoid

972

5505

1.46

26.03

1.4

1.2

—

Other and unspecified acquired haemolytic anaemias

8.55

26.00

1.3

1.2

—

Hypercalcemia

236

3.70

25.88

1.6

1.2

—

Thrombotic microangiopathy

10.66

25.88

1.5

1.3

—

Childhood asthma (age<16), excluding more controls

309

1258

1.97

25.81

1.3

1.2

—

Injury, poisoning and certain other consequences of external causes

873

2920

1.51

25.62

1.3

—

Other and unspecified diseases of blood and blood-forming organs

145

4.57

25.60

1.3

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

198

882

2.29

25.55

1.3

1.2

—

Isolated proteinuria with specified morphological lesion

6.64

25.54

1.7

1.2

—

External causes of morbidity and mortality

1051

3649

1.45

25.54

1.3

—

L04AC Interleukin inhibitors

138

524

2.73

25.45

1.2

—

Covid-19 suspected case

383

2156

1.80

25.44

1.4

1.2

—

Chronic myeloproliferative disease

7.23

25.44

1.4

1.3

—

Special screening examination for infectious and parasitic diseases

419

1756

1.78

25.33

1.2

—

Hypertensive Heart Disease

233

853

2.16

25.26

1.5

1.2

—

Major coronary heart disease event excluding revascularizations

618

2584

1.60

25.23

1.2

—

Other/unspecified dorsalgia

523

3179

1.65

25.18

1.3

1.2

—

Cholecystectomy

843

4933

1.48

25.18

1.3

1.2

—

Dysphagia

280

1430

1.98

25.07

1.3

1.2

—

Other headache syndromes

603

3831

1.59

24.98

1.2

—

Need for other prophylactic measures

126

461

2.83

24.96

1.6

1.3

—

Childhood asthma (age<16)

310

1280

1.94

24.91

1.3

1.2

—

Myalgia

360

2004

1.82

24.77

1.2

—

Cardiac arrest

226

3.47

24.67

1.6

1.2

—

Benign neoplasms

1528

6282

1.35

24.54

1.3

—

Hernia

1264

6167

1.38

24.54

1.4

1.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

204

935

2.22

24.54

1.3

1.2

—

Other general symptoms and signs

105

347

3.09

24.46

1.3

—

Injuries to the ankle and foot

1125

7210

1.40

24.26

1.3

—

Other symptoms and signs involving the digestive system and abdomen

219

1039

2.14

24.08

1.3

1.2

—

Heart failure and hypertrophic cardiomyopathy

5.62

24.07

1.6

1.2

—

Persons with potential health hazards related to communicable diseases

717

4741

1.52

24.01

1.4

1.3

—

Dental caries, including avohilmo

972

3444

1.45

23.78

1.3

1.2

—

Acute nephritic syndrome

150

4.40

23.76

1.7

1.2

—

Other or unspecified ileus, impaction or obstruction

213

1005

2.15

23.70

1.2

1.3

—

Other CVD

212

1003

2.14

23.44

1.3

1.2

—

Hernia of abdominal wall

577

3695

1.58

23.24

1.4

1.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

429

2559

1.70

23.12

1.3

—

Nonorganic sleeping disorders, excluding more controls

324

1787

1.84

23.08

1.2

1.3

—

Dermatitis due to substances taken internally

114

413

2.85

23.01

1.4

1.2

—

Melanocytic naevi

448

2708

1.68

23.00

1.5

1.2

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

104

5.07

23.00

1.4

1.2

—

Non-allergic asthma (mode), excluding more controls

232

1133

2.05

22.95

1.3

1.2

—

Benign neoplasm: Colon, unspecified

276

1448

1.93

22.91

1.2

—

Dorsalgia

1500

6037

1.34

22.85

1.2

1.3

—

Acute lymphocytic leukaemia, helper endpoint

104

5.62

22.84

1.5

1.9

—

Acute lymphocytic leukaemia

104

5.62

22.84

1.5

1.9

—

Acute lymphocytic leukaemia, including Hilmo

104

5.62

22.84

1.5

1.9

—

Marginal zone B-cell lymphoma, including Hilmo

6.05

22.73

1.1

—

Other arrhythmias

804

4149

1.47

22.65

1.3

1.2

—

Adverse effects, not elsewhere classified

344

1945

1.80

22.62

1.4

1.3

—

Microscopic polyangiitis

10.19

22.58

1.7

1.3

—

Accidents

1256

4599

1.38

22.57

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

104

362

2.94

22.47

1.4

1.1

—

Eosinophilia

107

5.01

22.38

1.4

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

109

388

2.84

22.34

1.2

—

Spondyloarthritis

256

1323

1.96

22.28

1.2

—

Total colectomy

323

3.09

22.25

1.2

1.3

—

Total colectomy operation

323

3.09

22.25

1.2

1.3

—

Viral warts

375

2186

1.74

22.16

1.7

1.3

—

Other and unspecified local infections of skin and subcutaneous tissue

168

745

2.31

22.06

1.5

1.3

—

COPD (mode)

274

1124

1.93

22.03

1.2

—

Chronic ulcer of skin, not elsewhere classified

102

356

2.93

21.95

1.4

1.2

—

Other local infections of skin and subcutaneous tissue

175

791

2.26

21.94

1.5

1.3

—

Other and unspecified effects of external causes

474

2944

1.63

21.92

1.4

1.3

—

Sleep apnoea

1202

5721

1.37

21.88

1.2

1.3

—

Non-allergic asthma (mode)

233

1162

2.01

21.78

1.3

1.2

—

Asthma, hospital admissions , main diagnosis only

1184

7726

1.36

21.76

1.3

—

Liver disorders in diseases classified elsewhere

23.68

21.67

1.1

1.3

—

Secondary right heart disease

201

3.65

21.64

1.3

1.2

—

Amputation of foot

126

4.49

21.58

1.6

1.1

—

Other complications of surgical and medical care, not elsewhere classified

161

708

2.32

21.55

1.4

1.2

—

Hypoplasia of dental enamel, prenatal

11.41

21.52

5.4

2.1

—

Congenital malformation of biliary tract

9.43

21.40

3.0

2.3

—

Other specified/unspecified systemic involvement of connective tissue

340

2.96

21.39

1.2

—

Acquired absence of organs, not elsewhere classified

6.69

21.32

1.7

1.1

—

Peripheral arterial reconstruction

173

786

2.23

21.26

1.5

1.2

—

Other pulmonary heart/vessel disease

233

3.41

21.19

1.3

—

Allergic asthma (mode), excluding more controls

342

1923

1.76

21.09

1.2

—

Actinic keratosis

321

1671

1.79

21.05

1.3

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

1554

6149

1.32

20.99

1.2

1.3

—

Obesity

902

6212

1.41

20.97

1.2

1.3

—

Obesity and other hyperalimentation

905

6229

1.41

20.94

1.2

1.3

—

Generalized skin eruption due to drugs and medicaments

292

3.14

20.92

1.5

1.3

—

Cerebrovascular diseases

804

3918

1.45

20.86

1.3

1.2

—

Elevated blood glucose level

140

588

2.44

20.86

1.6

1.3

—

DVT of lower extremities

226

1148

1.99

20.71

1.3

1.2

—

Urticaria

478

3017

1.60

20.67

1.4

1.3

—

359

1921

1.73

20.65

1.3

1.2

—

Mixed connective tissue disease

109

409

2.74

20.57

1.2

—

Subjective visual disturbances

347

2022

1.74

20.50

1.2

—

Hypoplasia of dental enamel, prenatal , including avohilmo

6.11

20.50

4.2

2.2

—

Other external causes of accidental injury

1239

4599

1.36

20.49

1.3

—

Acute generalized exanthematous pustulosis

322

2.99

20.49

1.5

1.3

—

Chronic lower respiratory diseases

1783

7416

1.29

20.48

1.3

—

Fibrosis of liver

7.78

20.40

1.5

1.2

—

Hypocalcemia

146

4.12

20.24

1.5

1.3

—

Hypotension

176

822

2.17

20.21

1.3

1.2

—

Diseases of the ear and mastoid process

1732

6774

1.29

20.09

1.3

1.2

—

Other diseases of upper respiratory tract

1558

6248

1.31

20.00

1.3

—

Osteonecrosis due to drugs

5.63

19.99

1.6

1.2

—

Skin changes due to chronic exposure to nonionizing radiation

328

1738

1.75

19.99

1.3

1.2

—

Recurrent aphthous stomatitis , including avohilmo

238

1252

1.94

19.83

1.5

1.2

—

Invasive ventilation

122

493

2.54

19.81

1.8

1.3

—

Other neurological diseases

831

4618

1.42

19.78

1.3

1.2

—

Use of pramipexole

256

1378

1.88

19.74

1.3

1.2

—

Dorsopathies

1582

6209

1.30

19.71

1.2

1.3

—

Atopic dermatitis

929

5508

1.39

19.56

1.3

—

Allergic asthma (mode)

342

1967

1.72

19.51

1.2

—

Pruritus

168

784

2.18

19.48

1.3

1.2

—

Caries of dentine, including avohilmo

1059

3946

1.38

19.47

1.3

—

Other renal tubulo-interstitial diseases

132

4.19

19.47

1.6

1.1

—

Stomatitis and related lesions

311

1788

1.77

19.37

1.5

1.3

—

Arterial embolism and thrombosis

256

3.15

19.37

1.4

1.2

—

Disturbances of skin sensation

402

2474

1.64

19.33

1.2

—

Constipation

1125

5793

1.35

19.27

1.3

—

Myeloproliferative diseases (CML excluded)

107

412

2.66

19.16

1.2

—

800

5129

1.42

19.15

1.2

1.3

—

Other diseases of lip and oral mucosa

522

3421

1.54

19.10

1.3

1.2

—

Malignant immunoproliferative diseases

6.40

19.06

1.7

1.2

—

Alcohol use disorder, Swedish definition

737

4734

1.44

18.97

1.2

1.3

—

Colectomy operation

203

1027

2.00

18.90

1.2

—

Dentofacial anomalies [including malocclusion]

1050

6257

1.36

18.81

1.4

1.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

454

2904

1.58

18.56

1.3

—

ILD medications: nintedanib

19.02

18.51

1.1

1.0

—

Other dorsopathies, not elsewhere classified

1503

6091

1.30

18.48

1.2

1.3

—

Exposure to other specified factors

1107

7642

1.34

18.44

1.3

—

Benzodiazepine use

1359

7200

1.31

18.36

1.2

—

Other disorders of glucose regulation and pancreatic internal secretion

151

693

2.23

18.35

1.5

1.4

—

Other diseases of pancreas

112

451

2.54

18.30

1.4

1.2

—

Polyarteritis nodosa and related conditions

4.96

18.30

1.5

1.4

—

Myocardial infarction, strict

441

1974

1.60

18.29

1.2

—

Mycoses

1193

7887

1.32

18.28

1.3

—

Asthma, including avohilmo

1703

7547

1.27

18.27

1.2

1.3

—

Personal history of other diseases and conditions

224

1184

1.92

18.24

1.4

1.1

—

Sleep apnoea, including avohilmo

1282

6055

1.32

18.21

1.2

1.3

—

Erythema multiforme

139

3.99

18.20

1.2

—

Ulcerative enterocolitis

211

3.35

18.11

1.2

—

Other specified disorders of kidney and ureter

196

3.44

18.11

1.6

1.2

—

Phobic anxiety disorders

276

1564

1.79

18.11

1.4

1.2

—

Melanocytic naevi of trunk

197

1005

2.00

18.04

1.6

1.2

—

Lower back pain or/and sciatica

1434

7269

1.29

18.02

1.2

—

Nonsuppurative otitis media

484

2729

1.56

18.00

1.6

1.3

—

Other juvenile arthritis

115

479

2.50

17.74

1.3

1.4

—

Fibromyalgia

147

677

2.21

17.69

1.2

—

Giant cell arteritis

179

3.51

17.66

1.1

1.2

—

Marginal zone B-cell lymphoma

7.89

17.63

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

1070

6097

1.34

17.62

1.3

—

830

5293

1.39

17.61

1.2

1.3

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

496

2913

1.54

17.55

1.6

1.3

—

Squamous cell neoplasms and carcinomas of the skin

245

3.06

17.46

1.2

1.1

—

Disorders of the thyroid gland

1265

6319

1.31

17.40

1.3

1.2

—

Hyperkinetic disorders, excluding more controls

274

1501

1.78

17.39

1.5

1.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

1325

7270

1.30

17.34

1.2

1.3

—

Other coagulation defects

124

537

2.36

17.33

1.3

1.2

—

Aspergillosis

6.41

17.33

1.5

1.2

—

Fluid overload

19.45

17.22

2.0

1.2

—

Other diseases of stomach and duodenum

319

2.79

17.18

1.4

1.2

—

Abnormality of white blood cells, not elsewhere classified

6.15

17.16

1.5

1.3

—

Medullary cystic kidney disease, nephronophthisis

39.24

17.04

1.7

1.3

—

Suppurative and unspecified otitis media

657

4080

1.44

17.00

1.4

1.2

—

Rheumatoid arthritis

366

2030

1.63

16.98

1.2

—

Umbilical hernia

362

2244

1.63

16.97

1.5

1.3

—

Other joint disorders

1364

5568

1.30

16.94

1.2

1.3

—

Dermatophytosis

179

904

2.01

16.86

1.4

1.2

—

AV-block

175

760

2.04

16.85

1.4

1.2

—

Acute lymphadenitis

123

540

2.34

16.75

1.4

1.3

—

Falls/tendency to fall

1633

6475

1.27

16.74

1.3

—

Other congenital malformations of the digestive system

124

545

2.35

16.72

2.1

1.6

—

Wegener granulomatosis

4.57

16.67

1.3

—

Disorder of lipoprotein metabolism, unspecified

140

648

2.19

16.58

1.3

1.2

—

Fall on same level

1689

7356

1.26

16.52

1.3

—

Nonhereditary hypogammaglobulinemia

5.38

16.51

1.3

—

Acute suppurative otitis media

526

3326

1.49

16.44

1.6

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

417

1798

1.58

16.42

1.3

1.2

—

Transport accidents

688

4202

1.42

16.40

1.3

—

Renal agenesis and other reduction defects of kidney

6.47

16.38

1.4

—

Other obstetric conditions, not elsewhere classified

561

2421

1.49

16.34

1.2

—

Personality disorders, excluding more controls

399

2555

1.58

16.32

1.2

—

Other congenital malformations of the digestive system

134

614

2.25

16.28

2.1

1.6

—

Obesity due to excess calories

663

4705

1.42

16.23

1.2

1.3

—

Seborrhoeic dermatitis

141

662

2.17

16.20

1.3

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

551

2372

1.49

16.12

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

685

4761

1.41

15.90

1.2

1.3

—

Nerve, nerve root and plexus disorders

1345

6442

1.28

15.85

1.3

1.2

—

Sulfasalazine

324

1988

1.64

15.82

1.2

—

Special screening examination for neoplasms

239

2.98

15.76

1.3

1.2

—

Encephalopathy

5.74

15.69

1.2

1.1

—

Cholecystitis

148

719

2.08

15.48

1.3

1.2

—

Panic disorder

267

1571

1.73

15.46

1.2

—

Enteropathic arthropathies

156

3.54

15.42

1.2

1.3

—

Sleep disorders

1245

7019

1.29

15.40

1.2

1.3

—

Post-traumatic stress disorder

174

901

1.97

15.39

1.3

1.2

—

Special screening examination for other diseases and disorders

155

768

2.05

15.39

1.4

1.2

—

Cytomegaloviral hepatitis

19.65

15.35

1.0

1.3

—

Chronic myeloid leukaemia, including Hilmo

6.01

15.35

1.1

—

Disorders of conjunctiva

1186

7403

1.29

15.30

1.3

—

Myocardial infarction, without ST-elevation

358

2060

1.59

15.30

1.2

—

Other arterial embolism and thrombosis

128

3.79

15.26

1.5

1.2

—

Migraine with aura

393

2549

1.56

15.26

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1267

6753

1.28

15.25

1.2

1.3

—

Polymyalgia rheumatica

124

567

2.21

15.17

1.2

—

Osteoporosis with pathological fracture (FG)

250

2.89

15.13

1.2

—

Substance abuse, excluding more controls

729

4518

1.38

15.12

1.2

—

Sicca syndrome [Sjögren]

113

499

2.31

15.12

1.1

1.2

—

Selective serotonin reuptake inhibitors

1403

5774

1.27

15.10

1.2

1.3

—

Other and unspecified coagulation defects

372

2.54

15.08

1.3

1.2

—

Erosion of teeth , including avohilmo

403

2639

1.54

15.03

1.7

1.3

—

Calcific aortic valvular stenosis, including rheumatic fever

242

1350

1.75

14.90

1.2

—

Drug-induced osteoporosis with pathological fracture

4.71

14.90

1.2

1.3

—

Benign neoplasm of other and ill-defined parts of digestive system

199

1086

1.85

14.86

1.2

—

Hypersensitivity angiitis

12.98

14.85

1.4

1.2

—

Renal agenesis and other reduction defects of kidney

6.32

14.81

1.5

1.4

—

Type 2 diabetes, definitions combined

1110

5012

1.31

14.80

1.3

1.2

—

Rheumatoid arthritis, including avohilmo

415

2741

1.53

14.77

1.1

1.2

—

Asthma and allergy, excluding more controls

210

1153

1.82

14.72

1.2

—

Other abnormalities of plasma proteins

4.65

14.68

1.7

1.3

—

Dermatopolymyositis (FG)

4.89

14.66

1.2

—

Conjunctivitis (acute, non atopic)

426

2826

1.52

14.66

1.5

1.3

—

Drug-induced adrenocortical insufficiency

105

4.10

14.62

1.7

1.4

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

13.89

14.60

1.6

2.3

—

Benign neoplasm: Transverse colon

129

610

2.15

14.59

1.2

—

Operations 2 for CAVS

240

1346

1.74

14.57

1.2

—

Calcific aortic valvular stenosis, diagnosis (helper)

240

1346

1.74

14.57

1.2

—

Retinal detachments and breaks

352

2250

1.58

14.53

1.3

1.2

—

Juvenile arthritis (FINNGEN)

119

549

2.24

14.53

1.4

—

Calcific aortic valvular stenosis

242

1362

1.73

14.51

1.2

—

Calcific aortic valvular stenosis, operated

242

1362

1.73

14.51

1.2

—

Decubitus ulcer and pressure area

291

2.70

14.41

1.6

1.2

—

Infections with a predominantly sexual mode of transmission

669

4518

1.39

14.41

1.2

—

Migraine without aura

349

2237

1.58

14.36

1.3

—

Heartburn

142

701

2.05

14.31

1.3

1.2

—

Other maternal disorders predominantly related to pregnancy

739

3382

1.38

14.31

1.2

—

Explicit fungal Sepsis

7.22

14.27

1.5

1.4

—

Hypothyroidism, other/unspecified

1158

5936

1.29

14.26

1.3

1.2

—

Other obstructive and reflux uropathy

299

2.68

14.26

1.5

1.2

—

Malignant neoplasm of skin

429

1945

1.52

14.25

1.2

—

Asthma and allergy

210

1165

1.80

14.24

1.2

—

Paracetamol or NSAID medication

329

1017

1.65

14.22

1.3

1.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

715

5253

1.37

14.19

1.3

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.21

14.19

2.0

1.4

—

Chronic sinusitis

546

3835

1.43

14.15

1.2

—

Viral infections of the central nervous system

129

620

2.12

14.06

1.2

—

Irregular menses

665

3803

1.39

14.06

1.3

1.2

—

Cardiodefibrillation

336

2140

1.58

13.97

1.3

1.2

—

Other specified/unspecified necrotizing vasculopathies

5.08

13.97

1.4

1.2

—

Intestinal malabsorption

320

2.60

13.96

1.4

1.2

—

Type 2 diabetes, strict (exclude DM1)

1114

5079

1.29

13.85

1.3

1.2

—

Iridocyclitis

297

1848

1.62

13.84

1.3

1.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1187

6114

1.28

13.80

1.3

1.2

—

Conjunctivitis

1086

7082

1.29

13.72

1.3

—

Corns and callosities

395

2.40

13.67

1.5

1.2

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.08

13.61

1.6

1.3

—

Injuries to the wrist and hand

1397

7768

1.25

13.60

1.2

1.3

—

Haemophagocytic lymphohistiocytosis

46.05

13.59

1.8

2.4

—

Early onset COPD

259

1566

1.67

13.54

1.2

—

Haemolytic-uraemic syndrome

14.39

13.53

2.0

1.4

—

Misadventures to patients during surgical and medical care

176

954

1.87

13.50

1.4

1.2

—

Rare circulating lymphoid malignancy

13.49

1.3

1.5

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

4.49

13.45

1.1

—

Acute posthaemorrhagic anaemia

155

3.31

13.35

1.4

1.1

—

Dermatopolymyositis

4.41

13.35

1.2

1.4

—

Lichen simplex chronicus and prurigo

369

2.43

13.32

1.4

1.2

—

Ventral hernia

262

1595

1.66

13.32

1.4

1.2

—

Hypersplenism

13.23

13.32

1.5

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

327

1928

1.58

13.27

1.3

1.2

—

Nonorganic sleeping disorders

324

2083

1.57

13.21

1.2

1.3

—

Angina pectoris

514

2385

1.44

13.20

1.3

1.2

—

Atopic dermatitis, strict definition with reimbursement

524

3578

1.43

13.19

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

1122

5111

1.28

13.19

1.2

—

Injuries to the head

1544

7714

1.24

13.16

1.3

—

Osteopathy in diseases classified elsewhere

6.58

13.15

2.0

1.5

—

Crohn's disease (strict) with PSC

21.48

13.11

1.4

1.6

—

Inflammatory diseases of female pelvic organs

761

4179

1.35

13.07

1.2

—

Pre-eclampsia or poor fetal growth

421

2856

1.48

13.04

1.2

—

Vasculitis limited to skin, not elsewhere classified

148

3.36

13.00

1.2

—

Somatoform disorder

224

1319

1.72

12.99

1.2

—

Generalized anxiety disorder

278

1733

1.63

12.96

1.2

—

Speech and linguistic disorders, excluding more controls

196

1048

1.80

12.92

1.8

1.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

490

3399

1.44

12.91

1.3

1.2

—

Stroke, excluding SAH

578

3021

1.40

12.90

1.3

1.2

—

In situ neoplasms

390

2619

1.50

12.89

1.3

1.2

—

Keratitis

459

3184

1.45

12.88

1.3

1.2

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

5.09

12.85

1.1

1.2

—

Thyroiditis, ILD-related definition

159

849

1.90

12.84

1.4

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

170

929

1.86

12.83

1.6

1.4

—

Inflammatory diseases of the central nervous system

130

650

2.04

12.77

1.3

—

Acquired absence of limb

5.77

12.76

1.5

1.1

—

Pre-eclampsia or eclampsia

284

1785

1.61

12.75

1.2

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

232

2.87

12.71

2.2

1.4

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

575

3605

1.40

12.71

1.2

—

Lupus nephritis

16.31

12.70

1.4

1.7

—

Hypoglycaemia, other or unspecified

118

571

2.11

12.70

1.4

—

Hypertrophic cardiomyopathy

276

2.65

12.70

1.6

1.2

—

Other leukaemias of specified cell type

16.69

12.68

1.5

1.3

—

Encephalitis

231

2.83

12.68

1.2

1.4

—

Carcinoma in situ of skin

377

2.37

12.68

1.4

1.1

—

Temporal arteritis

150

3.28

12.68

1.2

—

Vascular disorders of the intestines

275

2.62

12.66

1.3

1.2

—

Nonalcoholic steatohepatitis

5.36

12.65

1.2

—

Recurrent and persistent haematuria

5.17

12.62

1.4

1.3

—

Procreative management

557

3336

1.40

12.59

1.4

1.3

—

Fissure and fistula of anal and rectal regions

290

1838

1.59

12.54

1.2

—

Malignant neoplasm of digestive organs

313

1579

1.57

12.53

1.3

1.2

—

Other abnormal findings of blood chemistry

290

2.58

12.47

1.2

—

KRA_PSY_EATING, excluding more controls

170

933

1.85

12.46

1.3

1.2

—

Open wound of lower leg

218

1290

1.71

12.46

1.3

—

Other congenital malformations of urinary system

4.88

12.44

3.5

1.4

—

Background retinopathy and retinal vascular changes

113

3.67

12.41

1.4

1.1

—

Other disorders of adrenal gland

346

2.44

12.35

1.6

1.3

—

Other encephalitis

212

2.89

12.34

1.2

1.3

—

Abscess of anal and rectal regions

135

694

1.98

12.27

1.2

1.3

—

Viral infections of the central nervous system

117

572

2.09

12.26

1.2

—

Neuromuscular dysfunction of bladder

119

585

2.07

12.23

1.3

1.2

—

Carcinoma in situ of skin of upper limb, including shoulder

100

3.82

12.21

1.2

1.1

—

Stroke, including SAH

617

3271

1.37

12.20

1.3

1.2

—

Delirium, not induced by alcohol and other psychoactive substances

115

557

2.08

12.18

1.2

—

Late syphilis

4.19

12.12

1.5

1.2

—

Diseases of male genital organs

758

2862

1.34

12.12

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

363

1648

1.52

12.10

1.2

—

Giant cell arteritis with polymyalgia rheumatica

155

3.17

12.03

1.2

—

Cardiomyopathy, Hypertrophic obstructive

3.86

11.97

1.8

1.2

—

Other and unspecified urticaria

295

1901

1.57

11.96

1.4

1.3

—

Shock, not elsewhere classified

9.43

11.94

1.8

1.3

—

Chorioretinal inflammation

194

2.93

11.89

1.2

—

Malignant neoplasm of other and unspecified parts of biliary tract

5.09

11.79

1.0

1.1

—

Portal vein thrombosis

3.89

11.73

1.5

1.4

—

Adrenocortical insufficiency

229

2.74

11.71

1.7

1.3

—

Adult-onset Still disease

11.96

11.69

1.3

1.4

—

Disseminated intravascular coagulation [defibrination syndrome]

14.87

11.63

1.3

1.7

—

Hypertension, portal

14.87

11.63

1.3

1.5

—

Other specified/unspecified bacterial intestinal infections

420

2.23

11.50

1.3

1.2

—

Acne

235

1451

1.65

11.48

1.4

1.3

—

Seropositive rheumatoid arthritis

247

1534

1.62

11.46

1.1

1.2

—

Symptoms and signs involving speech and voice

361

2449

1.48

11.43

1.2

—

Pregnancy hypertension

524

3401

1.39

11.37

1.2

—

Other diseases of gallbladder

221

2.73

11.34

1.2

—

Problems related to lifestyle

163

914

1.81

11.33

1.2

—

Aortic valve malfunction, age under 60 years

148

807

1.87

11.31

1.5

1.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

440

2.21

11.21

1.9

1.4

—

Disorders of plasma-protein metabolism, not elsewhere classified

5.01

11.20

1.1

1.2

—

Juvenile rheumatoid arthirtis

179

2.96

11.18

1.3

—

Diseases of external ear

425

2988

1.43

11.18

1.4

1.3

—

Other epidermal thickening

288

2.49

11.16

1.5

1.3

—

Other follicular disorders

124

642

1.97

11.12

1.4

1.2

—

Other and unspecified vasculitis limited to skin

137

3.25

11.10

1.2

—

Acute and subacute iridocyclitis

244

1532

1.61

11.08

1.3

1.2

—

Rosacea

155

862

1.82

11.07

1.4

1.2

—

Injuries to the knee and lower leg

1631

7523

1.21

11.04

1.3

—

Haemorrhoids and perianal venous thrombosis

317

2105

1.51

11.02

1.2

—

Unknown and unspecified causes of morbidity

363

2.29

11.01

1.2

—

Small fibre neuropathy

181

2.91

10.93

1.5

1.2

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

461

2.13

10.92

1.3

—

Insomnia

1187

7002

1.24

10.90

1.2

1.3

—

Conduction disorders

290

1530

1.55

10.86

1.4

1.2

—

Chronic diseases of tonsils and adenoids

1137

5782

1.25

10.84

1.4

1.3

—

Diseases of salivary glands

394

2749

1.44

10.82

1.2

—

Retinal haemorrhage

109

3.49

10.78

1.7

1.2

—

Excessive, frequent and irregular menstruation

550

2194

1.38

10.73

1.3

1.2

—

Pre-eclampsia

263

1696

1.57

10.67

1.2

—

Presence of other devices

190

1125

1.69

10.65

1.3

1.1

—

Late syphilis

106

3.55

10.58

1.5

1.2

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

247

1575

1.59

10.56

1.2

—

Other sleep disorders

157

891

1.79

10.50

1.2

—

Infection of intervertebral disc (pyogenic)

4.11

10.46

1.2

—

Emphysema

360

2.25

10.36

1.2

—

Methotrexate

149

835

1.80

10.36

1.1

1.2

—

Unspecified privation

149

837

1.81

10.34

1.4

1.2

—

Infection due to other mycobacteria

4.67

10.32

1.3

1.2

—

Retention of urine

326

1806

1.49

10.32

1.3

1.2

—

Reactive arthropathies

118

616

1.94

10.31

1.2

—

Drug-induced hypoglycaemia without coma

3.61

10.31

1.4

1.2

—

Arthropathy in ulcerative colitis

3.78

10.26

1.2

1.3

—

Other mycoses, not elsewhere classified/unspecified

10.07

10.24

1.8

1.2

—

Temporomandibular joint disorders, including avohilmo

631

4727

1.32

10.21

1.2

—

Other overlap syndromes

3.56

10.14

1.1

1.3

—

Spondylopathies in diseases classified elsewhere

4.64

10.14

1.4

1.2

—

Dizziness and giddiness

867

5423

1.27

10.13

1.3

1.2

—

Chronic myeloid leukaemia

13.40

10.12

1.1

1.0

—

Anterior Iridocyclitis

252

1631

1.56

10.09

1.3

1.2

—

Erectile dysfunction

457

2.09

10.05

1.5

1.3

—

Infections with a predominantly sexual mode of transmission

463

3364

1.39

10.05

1.2

—

Weight loss

133

729

1.85

10.02

1.4

1.3

—

Fitting and adjustment of other devices

264

1553

1.54

10.01

1.3

1.1

—

Neovascular glaucoma

236

2.56

10.01

1.5

1.2

—

Excessive attrition of teeth

762

5956

1.29

9.99

1.5

1.2

—

Polymyositis

5.42

9.98

1.3

—

Lack of expected normal physiological development

270

2.40

9.96

2.5

1.4

—

Otitis externa

300

2022

1.50

9.94

1.4

1.3

—

Artificial opening status

285

2.39

9.94

1.7

1.1

—

Discitis, unspecified

3.74

9.93

1.4

1.2

—

Abnormal weight loss

121

646

1.90

9.91

1.3

—

Obesity, other/unspecified

447

3245

1.39

9.83

1.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

421

3027

1.40

9.82

1.4

1.3

—

Other disorders of eye and adnexa

201

1243

1.64

9.82

1.3

—

Cyst of kidney

369

2.20

9.80

1.4

1.2

—

Prurigo nodularis

122

3.21

9.70

1.4

1.2

—

Visual impairment including blindness (binocular or monocular)

404

2.14

9.66

1.4

1.3

—

Lung diseases due to external agents

139

780

1.80

9.66

1.2

—

Fentanyl

476

2.03

9.65

1.3

1.2

—

Chronic viral hepatitis

493

2.03

9.64

1.2

—

Unspecified contracted kidney

7.55

9.61

1.8

1.2

—

Noninflammatory disorders of female genital tract

605

2279

1.34

9.61

1.3

1.2

—

Membranous nephropathy

10.62

9.59

2.3

1.4

—

Carcinoma in situ of skin of other and unspecified parts of face

308

2.30

9.58

1.2

1.1

—

Pulmonary oedema

4.11

9.57

1.6

1.2

—

Degenerative macular diseases

104

534

1.97

9.53

1.2

1.1

—

Other diseases of oesophagus

100

508

1.99

9.47

1.4

1.2

—

Drug-induced osteoporosis

4.12

9.45

1.3

1.1

—

Glaucoma secondary to other eye disorders

243

2.48

9.43

1.5

1.2

—

Unspecified misadventure during surgical and medical care

343

2.23

9.43

1.4

1.2

—

Carrier of infectious disease

185

2.74

9.42

1.2

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

7.74

9.41

1.5

1.1

—

Open wound of ankle and foot

159

937

1.72

9.39

1.3

1.2

—

Concussion

688

4352

1.30

9.39

1.3

—

Other and unspecified follicular disorders

306

2.31

9.38

1.3

1.2

—

Adult respiratory distress syndrome

3.97

9.35

1.6

1.2

—

Rash and other nonspecific skin eruption

126

695

1.84

9.33

1.3

—

Voice disturbances

288

1951

1.49

9.31

1.2

—

Bacterial, viral and other infectious agents

145

836

1.76

9.29

1.5

1.3

—

Ischaemic Stroke, excluding all haemorrhages

506

2794

1.35

9.27

1.3

1.2

—

Melanocytic naevi, other sites/unspecified

119

647

1.87

9.26

1.5

1.2

—

Ocular pain

124

683

1.85

9.26

1.3

—

Ovarian cyst

472

1988

1.38

9.22

1.2

—

Tonsillectomy and adenotomy

941

5275

1.25

9.17

1.4

1.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

502

3753

1.35

9.15

1.3

—

Spondylopathies (FG)

192

1196

1.62

9.13

1.2

—

Systemic sclerosis (FG)

111

3.24

9.13

1.2

1.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

155

902

1.73

9.12

1.7

1.4

—

Bacterial, viral and other infectious agents

136

774

1.79

9.12

1.6

1.3

—

Allergic purpura

242

2.47

9.08

1.3

—

Psoriatic and enteropathic arthropathies

149

872

1.73

9.01

1.2

—

Vasomotor and allergic rhinitis

553

4125

1.32

9.01

1.2

1.3

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

195

2.62

8.97

1.2

—

Malignant neoplasm of kidney, except renal pelvis

396

2.10

8.95

1.3

1.2

—

Otitis media, unspecified

236

1426

1.55

8.93

1.8

1.3

—

Malignant neoplasm of urinary organs

430

2.05

8.92

1.3

1.2

—

Nail disorders

122

678

1.83

8.87

1.4

1.3

—

Fracture of lumbar spine and pelvis

208

1326

1.58

8.87

1.3

1.2

—

Dermatographic urticaria

103

545

1.92

8.76

1.4

1.2

—

Other disorders starting during childhood or adolecense, excluding more controls

130

709

1.80

8.76

2.1

1.4

—

Valvular operations

139

805

1.74

8.71

1.4

1.3

—

Migraine without aura and triptan purchases

266

1803

1.49

8.68

1.3

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

379

2726

1.39

8.67

1.2

—

Diplopia

156

935

1.69

8.66

1.2

—

Disorders of psychological development

277

1756

1.48

8.64

1.7

1.4

—

Mental and behavioural disorders due to psychoactive substance use

772

5697

1.26

8.64

1.2

1.3

—

UC patients in KELA-register (code 208), prior to 1994

260

2.36

8.61

1.3

1.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

208

1339

1.57

8.61

1.3

1.4

—

Polycythaemia vera

142

2.87

8.59

1.2

1.1

—

Acquired pure red cell aplasia [erythroblastopenia]

9.37

8.56

1.2

1.8

—

Myositis

171

2.71

8.55

1.3

1.2

—

Migraine with aura and triptan purchases

252

1695

1.50

8.55

1.2

—

Injuries to unspecified part of trunk, limb or body region

141

826

1.73

8.55

1.3

—

Acne vulgaris

180

1126

1.63

8.54

1.4

1.3

—

Cardiac murmurs and other cardiac sounds

164

990

1.66

8.51

1.4

—

Other (seronegative) rheumatoid arthritis, wide

191

1209

1.59

8.50

1.2

—

Sequelae of cerebrovascular disease

293

1743

1.46

8.47

1.2

—

COPD, hospital admission 2, with asthma infections

273

1593

1.48

8.45

1.2

—

Disorders of adult personality and behaviour

435

3228

1.36

8.44

1.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

104

559

1.89

8.43

1.3

1.2

—

Granulomatous disorders of skin and subcutaneous tissue

167

2.71

8.38

1.6

1.3

—

Cryoglobulinemia

16.30

8.36

1.4

—

Social phobias

162

992

1.66

8.35

1.3

1.2

—

Infarction of spleen

8.05

8.34

1.3

1.1

—

Intracranial trauma

792

4448

1.26

8.33

1.3

—

Traction detachment of retina

4.43

8.33

1.9

1.2

—

Pyogenic arthritis

401

2.05

8.32

1.3

1.2

—

Injuries to the hip and thigh

495

3388

1.33

8.31

1.3

1.2

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

229

1518

1.52

8.30

1.3

1.4

—

Type of accident

381

2777

1.38

8.28

1.4

1.3

—

Fracture of foot, except ankle

338

2417

1.41

8.25

1.4

1.3

—

Drug-induced polyneuropathy

3.98

8.24

1.5

2.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

120

679

1.79

8.23

1.3

1.2

—

Otitis externa, unspecified

166

1026

1.64

8.23

1.5

1.3

—

Other and unspecified rosacea

107

585

1.85

8.22

1.2

—

Helminthiases

119

3.05

8.20

1.5

1.4

—

Other symptoms and signs involving cognitive functions and awareness

444

3014

1.35

8.19

1.2

—

Other eating disorders

111

617

1.84

8.15

1.3

—

Viral agents as the cause of diseases classified to other chapters

176

2.65

8.13

1.9

1.3

—

Other and unspecified disorders of skin and subcutaneous tissue

378

2.07

8.12

1.3

1.2

—

Acidosis

125

2.97

8.11

1.7

1.2

—

Atopic dermatitis, strict definition

505

3782

1.32

7.98

1.4

1.3

—

Other specified and unspecified retinal disorders

201

2.49

7.97

1.4

1.2

—

Familial hypercholesterolemia

127

737

1.74

7.94

1.4

1.2

—

Injuries to the thorax

502

3837

1.31

7.89

1.3

1.2

—

Malnutrition

173

2.63

7.88

2.6

1.7

—

Other symptoms and signs involving the circulatory and respiratory systems

458

1.95

7.88

1.3

1.2

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1010

5623

1.22

7.87

1.2

—

Syphilis

185

2.56

7.84

1.4

1.1

—

Syphilis

185

2.56

7.84

1.4

1.1

—

Sickle-cell disorders

11.46

7.83

1.3

1.1

—

Necrobiosis lipoidica, not elsewhere classified

4.82

7.80

1.6

1.2

—

Xerosis cutis

3.64

7.78

1.2

1.3

—

Amyloidosis, other/unspecified

3.23

7.77

1.5

1.1

—

Disturbance of activity and attention

265

1802

1.46

7.76

1.5

1.3

—

Injury of unspecified body region

105

582

1.83

7.75

1.4

1.3

—

Folate deficiency anaemia

4.69

7.74

1.3

1.2

—

Benign neoplasm: Ascending colon

130

766

1.71

7.73

1.2

—

Retinal vascular disorders

102

560

1.84

7.71

1.3

1.1

—

Systemic sclerosis

123

2.92

7.71

1.2

1.3

—

Aortic aneurysm

190

1206

1.55

7.68

1.3

1.2

—

Restrictive cardiomyopathy

8.55

7.67

2.5

1.1

—

Acute gastritis

407

1.99

7.65

1.3

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

499

1.90

7.64

1.4

1.3

—

Personality disorders

399

2971

1.35

7.62

1.2

—

Acute bronchiolitis

174

1001

1.60

7.59

2.0

1.5

—

Colonic or urogenital fistula

307

2193

1.41

7.57

1.2

—

Polyarteritis nodosa

6.83

7.56

1.4

1.2

—

Sequelae of other external causes

389

2.01

7.55

1.3

1.2

—

Polyarthritis, unspecified

213

2.39

7.50

1.2

—

Disorders of muscles

131

781

1.70

7.50

1.2

—

Scleritis and episcleritis

453

1.93

7.48

1.3

1.2

—

Essential (haemorrhagic) thrombocythaemia

183

2.51

7.46

1.1

1.2

—

Dental pulpitis, including avohilmo

1283

7051

1.18

7.46

1.2

1.3

—

Retinal vascular occlusion

100

552

1.83

7.45

1.3

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

395

2948

1.35

7.42

1.4

1.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

215

1225

1.51

7.42

1.2

—

Polyuria

217

1459

1.50

7.40

1.2

—

Basal cell carcinoma

317

1566

1.41

7.39

1.2

—

Hyperhidrosis

172

2.55

7.38

1.2

—

Calcinosis cutis

23.08

7.38

1.5

1.2

—

Scleritis

3.42

7.35

1.4

1.2

—

Bipolar affective disorders

270

1898

1.43

7.34

1.2

—

Amenorrhoea

121

712

1.73

7.32

1.2

—

Diseases of the myoneural junction and muscle

135

817

1.67

7.30

1.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified

332

2422

1.38

7.28

1.2

—

Shoulder lesions

825

4066

1.23

7.24

1.3

1.2

—

Postprocedural disorders of nervous system

114

662

1.75

7.23

1.1

1.2

—

Fracture of rib(s), sternum and thoracic spine

304

2186

1.40

7.22

1.2

—

Specific development disorders of scholastic skills

121

708

1.73

7.22

1.7

1.5

—

Malignant melanoma, including Hilmo

140

857

1.65

7.21

1.3

1.2

—

Intestinal adhesions without obstruction

451

1.91

7.20

1.2

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

21.22

7.15

1.6

1.5

—

Benign neoplasm: Caecum

100

560

1.80

7.14

1.2

—

Hyperkinetic disorders

279

1945

1.42

7.13

1.5

1.4

—

Unspecified fall

610

4776

1.26

7.13

1.3

—

Coeliac disease

167

1073

1.57

7.10

1.4

1.3

—

Other and unspecified vascular occlusions

404

1.95

7.09

1.3

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

244

1694

1.45

7.08

1.1

1.2

—

Mixed hyperlipidaemia

219

2.32

7.06

1.3

1.1

—

Other shoulder lesions

120

711

1.71

7.06

1.3

1.2

—

Other/unspecified seropositive rheumatoid arthritis

246

1712

1.45

7.04

1.1

1.2

—

Carcinoma in situ of skin of ear and external auricular canal

3.96

7.04

1.4

1.2

—

Sacroiliitis, not elsewhere classified

449

1.91

7.03

1.3

1.2

—

Other salmonella infections

284

2.15

7.03

1.1

1.2

—

Congenital malformations of the circulatory system

234

1568

1.46

7.02

1.7

1.5

—

Amyloidosis

113

2.90

7.02

1.5

1.1

—

Hydrocele

129

780

1.67

7.01

1.4

1.3

—

Excessive vomiting in pregnancy

116

683

1.72

7.00

1.2

—

Emotional disorders starting during childhood or adolecense, excluding more controls

116

668

1.73

6.99

1.5

1.4

—

Diabetes mellitus in pregnancy

463

2264

1.32

6.99

1.2

—

Embedded and impacted teeth

516

3323

1.29

6.93

1.4

1.3

—

Polycystic ovarian syndrome, consortium definition

857

4168

1.22

6.91

1.3

1.2

—

Other (not insulin) diabetes medications

1070

5323

1.20

6.88

1.2

—

Right hemicolectomy

273

2.15

6.88

1.2

—

Carcinoma in situ of skin of trunk

131

2.72

6.88

1.2

1.1

—

Basal cell carcinoma, including avohilmo

333

1674

1.38

6.86

1.2

—

Hordeolum and other deep inflammation of eyelid

489

1.85

6.84

1.3

—

Hyphaema and other vascular disorders of iris and ciliary body

115

2.86

6.82

1.3

1.2

—

Acute laryngitis and tracheitis

205

1366

1.49

6.82

1.4

1.3

—

Systemic sclerosis, icd10

132

2.72

6.80

1.2

1.3

—

Primary hyperparathyroidism

104

599

1.75

6.78

1.2

—

Duodenal ulcer

504

1.82

6.75

1.4

1.2

—

Seropositive rheumatoid arthritis, wide

247

1735

1.43

6.75

1.1

1.2

—

Persistent mood disorders

227

1572

1.45

6.72

1.2

—

COPD related to multimorbidity

318

1963

1.37

6.70

1.2

—

Superficial injury of lower leg

324

2387

1.37

6.70

1.2

1.3

—

Disorders of continuity of bone

130

799

1.65

6.68

1.3

—

Cytomegaloviral pneumonitis

16.67

6.65

1.9

1.4

—

Substance abuse

729

5594

1.23

6.64

1.2

1.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

179

1185

1.52

6.62

1.3

1.2

—

Emotionally unstable personality disorder

205

1399

1.48

6.61

1.2

—

Anuria and oliguria

6.49

6.58

2.2

1.5

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

5.57

6.58

1.2

—

Degeneration of macula and posterior pole

351

2077

1.35

6.57

1.2

—

Other mycoses, not elsewhere classified/unspecified

112

2.86

6.57

1.6

1.2

—

Allergic rhinitis

488

3778

1.29

6.53

1.2

1.3

—

Speech and linguistic disorders

206

1355

1.48

6.53

1.8

1.5

—

Other salmonella infections

227

2.24

6.53

1.2

—

Viral agents as the cause of diseases classified to other chapters

215

2.30

6.52

1.9

1.4

—

Urolithiasis

327

2422

1.36

6.52

1.3

1.2

—

Specific personality disorders

345

2579

1.35

6.51

1.2

—

Diseases of tongue

341

1.99

6.47

1.5

1.1

—

Injuries to the neck

307

2257

1.37

6.46

1.2

—

Hypermobility syndrome

484

1.83

6.46

1.1

1.2

—

Benign neoplasm: Stomach

542

1.77

6.43

1.2

—

Spondylopathies

849

4194

1.21

6.40

1.2

—

Cervicalgia

220

1531

1.45

6.36

1.2

—

Certain conditions originating in the perinatal period

216

1331

1.46

6.35

1.9

1.4

—

Autonomic disorders

149

2.55

6.34

1.4

1.2

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

3.97

6.33

1.4

1.0

—

Varicella [chickenpox]

452

1.85

6.30

1.6

1.3

—

Moderate visual impairment, binocular

126

2.66

6.26

1.5

1.2

—

Injuries to the shoulder and upper arm

1012

6895

1.19

6.24

1.2

1.3

—

Eating disorders

192

1308

1.48

6.24

1.3

—

Other disorders of bone

253

1813

1.41

6.24

1.3

—

Varicella [chickenpox]

556

1.76

6.23

1.6

1.4

—

Respiratory conditions due to other external agents

2.97

6.21

1.2

—

Malignant neoplasm, without specification of site, including Hilmo

168

2.41

6.21

1.2

1.1

—

Other peripheral vascular diseases

534

1.76

6.18

1.1

1.2

—

Underdevelopment of the second kidney

11.42

6.16

1.7

2.0

—

Disorders of optic nerve, not elsewhere classified

116

2.74

6.15

1.2

—

Allergic bronchopulmonary aspergillosis (ABPA)

10.68

6.14

1.3

1.4

—

Unspecific neurodegenerative disorder

124

1345

0.63

6.13

1.0

1.2

—

Thyrotoxicosis, other and/or unspecified

221

1551

1.43

6.13

1.2

—

Tooth eruption problems

301

2173

1.37

6.13

1.6

1.3

—

Drug-induced aplastic anaemia

17.33

6.12

1.3

1.2

—

Reactive arthropathies, FINNGEN

536

1.76

6.12

1.2

—

Pollen allergy

344

2566

1.34

6.09

1.2

1.4

—

Other and unspecified acne

141

2.58

6.07

1.7

1.2

—

Other condition

192

1317

1.47

6.05

1.4

1.2

—

Carcinoma in situ of skin of scalp and neck

100

2.86

6.04

1.3

1.1

—

Complications following infusion, transfusion and therapeutic injection

2.93

6.02

1.9

1.3

—

Substance use, excluding alcohol

278

2037

1.38

6.02

1.2

1.3

—

Anomalies of dental arch relationship, including avohilmo

331

2243

1.34

6.00

1.8

1.3

—

Intracranial injury

715

5573

1.22

6.00

1.2

1.3

—

Disorders of optic nerve and visual pathways

129

815

1.60

5.98

1.3

—

Acute appendicitis

871

6837

1.19

5.96

1.2

—

Intracranial and intraspinal abscess and granuloma

3.31

5.96

1.3

1.2

—

Agoraphobia

325

1.98

5.95

1.2

—

Disorder of the sleep-wake schedule

186

2.34

5.92

1.3

1.5

—

Henoch-Schönlein purpura nephritis (HSPN)

5.70

5.92

1.5

1.2

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

180

2.37

5.91

2.0

1.6

—

Sciatica+with lumbago

566

4194

1.25

5.91

1.2

—

Congenital vesicoureteral reflux

109

2.88

5.91

2.5

1.6

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS